United Therapeutics Corporation v. Liquidia Technologies, Inc. > Documents

Date Field	Doc. No.	Description (Pages)
Mar 28, 2024	481	Notice of Appeal* (1)
Oct 3, 2022	447	Complaint?* (1)
Sep 12, 2022	440	Notice of Appeal* (1)
Jul 19, 2022	425	Main Document (2) Docket Text: NOTICE of Subsequent Authority by Liquidia Technologies, Inc. (Attachments: # (1) Exhibit 1)(Hoeschen, Nathan)
Jul 19, 2022	425	Exhibit 1 (50)
Jul 15, 2022	423	Main Document (7) Docket Text: Letter to The Honorable Judge Richard G. Andrews, from Nathan R. Hoeschen, regarding dispute whether the treprostinil disclosed in Moriarty can anticipate the claimed pharmaceutical composition[product] comprising treprostinil. (Attachments: # (1) JTX2, # (2) Trial Transcript Excerpts, # (3) DTX258)(Hoeschen, Nathan) Modified on 7/18/2022 (nms).
Jul 15, 2022	423	JTX2 (13)
Jul 15, 2022	423	Trial Transcript Excerpts (25)
Jul 15, 2022	423	DTX258 (14)
Jul 15, 2022	424	Main Document (5) Docket Text: Letter to The Honorable Richard G. Andrews, from Michael J. Flynn, regarding discovery dispute. (Attachments: # (1) Exhibits A-B)(Flynn, Michael) Modified on 7/18/2022 (nms).
Jul 15, 2022	424	Exhibits A-B (17)
Jul 12, 2022	N/A	Oral Order (0) Docket Text: ORAL ORDER: In the post-trial briefing, the parties dispute whether the treprostinil disclosed in Moriarty can anticipate the claimed pharmaceutical composition[/product] comprising treprostinil. (D.I. 413 at 8-9; D.I. 415 at 1). The Court requests further briefing on this issue. Specifically, the parties should address the following issues: (1) whether the terms pharmaceutical composition (claim 1) and pharmaceutical product (claim 9) carry patentable weight; and (2) whether treprostinil is a pharmaceutical composition[/product] comprising treprostinil. Each party should submit a letter not exceeding four pages by Friday, July 15. Ordered by Judge Richard G. Andrews on 7/12/2022. (nms)
Jul 7, 2022	420	Main Document (3) Docket Text: Letter to The Honorable Richard G. Andrews, from Michael Flynn responding to Liquidia's June 30, 2022, letter (D.I. [419]). (Attachments: # (1) Exhibit 1)(Flynn, Michael) Modified on 7/7/2022 (nms).
Jul 7, 2022	420	Ex. 1 (4)
Jun 30, 2022	419	Main Document (2) Docket Text: Letter to Honorable Richard G. Andrews from Nathan R. Hoeschen regarding Drug Master File Exhibits. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Hoeschen, Nathan)
Jun 30, 2022	419	Exhibit A (4)
Jun 30, 2022	419	Exhibit B (5)
Jun 22, 2022	417	Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Michael Flynn regarding Plaintiffs' Hyperlinked Post Trial Briefs. (Flynn, Michael)
Jun 22, 2022	418	Notice of Filing Multi Media Materials (2) Docket Text: NOTICE of filing Defendant's Hyperlinked Post-Trial Opening Brief (D.I. 406 and 407); Defendant's Hyperlinked Post-Trial Answering Brief (D.I. 411 and 412); Defendant's Hyperlinked Post-Trial Reply (D.I. 415). Original Non-paper material(s) to be filed with the Clerk's Office. Notice, filed by Nathan Roger Hoeschen on behalf of Liquidia Technologies, Inc. (Hoeschen, Nathan) Modified on 6/22/2022 (nms).
Jun 16, 2022	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for D.I. [415] has been replaced per counsel's request. Typographical errors have been corrected. The NEF for the filing has been regenerated. (nms)
Jun 15, 2022	415	POST Trial Brief (16) Docket Text: Post-Trial Reply Brief Regarding Invalidity of U.S. Patent Nos. 9,593,066 and 10,716,793, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 6/15/2022 (nms). (Main Document 415 replaced on 6/16/2022) (nms).
Jun 15, 2022	416	POST Trial Brief (19) Docket Text: Reply Post-Trial Brief, by United Therapeutics Corporation. (Flynn, Michael) Modified on 6/15/2022 (nms).
Jun 1, 2022	411	POST Trial Brief (24) Docket Text: Post-Trial Answering Brief Regarding Non-Infringement, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 6/2/2022 (nms).
Jun 1, 2022	412	Proposed Findings of Fact (21) Docket Text: Proposed Findings of Fact by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Jun 1, 2022	413	POST Trial Brief (30) Docket Text: Answering Post-Trial Brief, by United Therapeutics Corporation. (Flynn, Michael) Modified on 6/2/2022 (nms).
Jun 1, 2022	414	Proposed Findings of Fact (26) Docket Text: Proposed Findings of Fact by United Therapeutics Corporation. (Flynn, Michael)
May 12, 2022	410	Memorandum and Order (3) Docket Text: MEMORANDUM ORDER: The Report & Recommendation (D.I. [360]) is ADOPTED to the extent necessary as to the above discussion. Liquidia's Motion for Summary Judgment (D.I. [281]) is DENIED. Signed by Judge Richard G. Andrews on 5/12/2022. (nms)
May 4, 2022	406	POST Trial Brief (30) Docket Text: POST-TRIAL Opening Brief Regarding Invalidity of U.S. Patent Nos. 9,593,066 and 10,716,793, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 5/5/2022 (nms).
May 4, 2022	407	Proposed Findings of Fact (30) Docket Text: Proposed Findings of Fact by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
May 4, 2022	408	POST Trial Brief (30) Docket Text: POST-TRIAL Opening Post-Trial Brief, by United Therapeutics Corporation. (Flynn, Michael) Modified on 5/5/2022 (nms).
May 4, 2022	409	Proposed Findings of Fact (29) Docket Text: Proposed Findings of Fact by United Therapeutics Corporation. (Flynn, Michael)
May 2, 2022	402	Transcript (302) Docket Text: Official Transcript of Bench Trial held on 3/28/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/23/2022. Redacted Transcript Deadline set for 6/2/2022. Release of Transcript Restriction set for 8/1/2022. (Triozzi, Heather)
May 2, 2022	403	Transcript (317) Docket Text: Official Transcript of Bench Trial held on 3/29/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/23/2022. Redacted Transcript Deadline set for 6/2/2022. Release of Transcript Restriction set for 8/1/2022. (Triozzi, Heather)
May 2, 2022	404	Transcript (270) Docket Text: Official Transcript of Bench Trial held on 3/30/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/23/2022. Redacted Transcript Deadline set for 6/2/2022. Release of Transcript Restriction set for 8/1/2022. (Triozzi, Heather)
May 2, 2022	405	Transcript (81) Docket Text: Official Transcript of Bench Trial held on 3/31/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/23/2022. Redacted Transcript Deadline set for 6/2/2022. Release of Transcript Restriction set for 8/1/2022. (Triozzi, Heather)
Apr 25, 2022	401	Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Nathan Roger Hoeschen (Hoeschen, Nathan)
Apr 18, 2022	399	Stipulation (2) Docket Text: STIPULATION and [Proposed] Order on Post-Trial Briefing - by United Therapeutics Corporation. (Flynn, Michael)
Apr 18, 2022	400	Order (2) Docket Text: SO ORDERED Granting [399] Stipulation and Proposed Order on Post-Trial Briefing. Signed by Judge Richard G. Andrews on 4/18/2022. (nms)
Apr 13, 2022	396	Redacted Document (18) Docket Text: REDACTED VERSION of [377] Objection to Report and Recommendations by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Apr 13, 2022	397	Response to Objections (16) Docket Text: RESPONSE to [377] Objections, by United Therapeutics Corporation. (Flynn, Michael) Modified on 4/14/2022 (nms).
Apr 13, 2022	398	Main Document (3) Docket Text: DECLARATION of Michael J. Flynn re [397] Response to Objections, by United Therapeutics Corporation. (Attachments: # (1) Exhibit A)(Flynn, Michael) Modified on 4/14/2022 (nms).
Apr 13, 2022	398	Ex. A (30)
Apr 12, 2022	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 396 removed re filing error. (lak)
Apr 11, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [393] STIPULATION to Extend Time to submit a final list of exhibits admitted at trial to April 11, 2022. Signed by Judge Richard G. Andrews on 4/11/2022. (nms)
Apr 11, 2022	394	Redacted Document (6) Docket Text: REDACTED VERSION of [386] Declaration by Liquidia Technologies, Inc.. (DiBenedetto, Emily)
Apr 11, 2022	395	Exhibit List (12) Docket Text: Admitted Exhibit List, by United Therapeutics Corporation. (Simonetti, Sarah) Modified on 4/12/2022 (nms).
Apr 8, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [392] STIPULATION to Extend Time to submit a final list of exhibits admitted at trial to April 8, 2022. Signed by Judge Richard G. Andrews on 4/8/2022. (nms)
Apr 8, 2022	393	Stipulation to EXTEND Time (1) Docket Text: STIPULATION To Extend Time to submit a final list of exhibits admitted at trial to April 11, 2022 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 4/11/2022 (nms).
Apr 7, 2022	389	Main Document (4) Docket Text: NOTICE of Lodging of Plaintiff's Trial Demonstratives by United Therapeutics Corporation (Attachments: # (1) Exhibits 1-10)(Flynn, Michael)
Apr 7, 2022	389	Exhibits 1-10 (170)
Apr 7, 2022	390	Transcript (14) Docket Text: Official Transcript of Report and Recommendation held on 03/11/22 before Judge Jennifer L. Hall. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/28/2022. Redacted Transcript Deadline set for 5/9/2022. Release of Transcript Restriction set for 7/6/2022. (Triozzi, Heather)
Apr 7, 2022	391	Main Document (2) Docket Text: NOTICE of Lodging of Defendant's Trial Demonstratives by Liquidia Technologies, Inc. (Attachments: # (1) Exhibts 1-6)(Hoeschen, Nathan)
Apr 7, 2022	391	Exhibts 1-6 (48)
Apr 7, 2022	392	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit a final list of exhibits admitted at trial to April 8, 2022 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Apr 5, 2022	N/A	Oral Order (0) Docket Text: ORAL ORDER: The redaction version of D.I. 344 (D.I. [385]) as supported by the Declaration (D.I. [386]) is APPROVED. Ordered by Judge Richard G. Andrews on 4/5/2022. (nms)
Apr 4, 2022	N/A	Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. § 652(b). (Taylor, Daniel)
Apr 4, 2022	385	Redacted Document (30) Docket Text: REDACTED VERSION of [344] Declaration by Liquidia Technologies, Inc.. (DiBenedetto, Emily)
Apr 1, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [384] STIPULATION to Extend Time to file its response to Objections to Report & Recommendation to April 13, 2022. Signed by Judge Richard G. Andrews on 4/1/2022. (nms)
Apr 1, 2022	384	Stipulation to EXTEND Time (1) Docket Text: STIPULATION to Extend Time to file its response to Objections to Report & Recommendation to April 13, 2022 - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 4/1/2022 (nms).
Mar 31, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [383] STIPULATION TO EXTEND TIME to submit a proposed public version of Liquidia Technologies, Inc.'s Objection to Report and Recommendation (D.I. 377) to April 13, 2022. Signed by Judge Richard G. Andrews on 3/31/2022. (nms)
Mar 31, 2022	N/A	Bench Trial - Completed (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 4 completed on 3/31/2022. Local counsel present for Plaintiff: M. Flynn. Local counsel present for Defendant: K. Keller. Closing arguments made. (Court Reporter Heather Triozzi.) (lak)
Mar 31, 2022	388	Exhibit List (2) Docket Text: Witness list for Bench Trial held on 3/28/2022 - 3/31/2022. (lak) (Main Document 388 replaced on 4/12/2022) (lak).
Mar 30, 2022	N/A	Bench Trial - Held (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 3 held on 3/30/2022. Local counsel present for Plaintiff: M. Flynn. Local counsel present for Defendant: K. Keller. Witnesses: Dr. Aaron Waxman, Dr. Nicholas Hill, Dr. Igor Gonda, Dean Bunce, Dr. David Walsh, Dr. Karl Scheidt, Dr. Andrew Clark, Dr. Hugh Smyth. (Court Reporter Heather Triozzi.) (lak)
Mar 30, 2022	383	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed public version of Liquidia Technologies, Inc.'s Objection to Report and Recommendation (D.I. 377) to April 13, 2022 - filed by United Therapeutics Corporation. (Simonetti, Sarah)
Mar 29, 2022	N/A	Bench Trial - Held (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 2 held on 3/29/2022. Local counsel present for Plaintiff: M. Flynn. Local counsel present for Defendant: K. Keller. Witnesses: Jeffrey Kindig, deposition of Hamilton Lennox, John Fuson, Dr. Jeffrey Winkler, deposition of Dr. Hitesh Batra, deposition of Dr. Sudersan Tuladhar, Dr. Nicholas Hill, deposition of Dr. Lewis Rubin. (Court Reporter Heather Triozzi.) (lak)
Mar 28, 2022	N/A	Bench Trial - Begun (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 1 held on 3/28/2022. Local counsel present for Plaintiff: M. Flynn. Local counsel present for Defendant: K. Keller. Opening statements made. Witnesses: Patrick Poisson, deposition of Jeffrey Kindig, deposition of Todd Battistoni, Dr. Colin Nuckolls, Dr. F. Dean Toste, deposition of Kelli Collin, deposition of Marisa Law, Cesar Matto, deposition of Dr. Benjamin Maynor, deposition of Robert Roscigno, deposition of Dr. Werner Seeger. (Court Reporter Heather Triozzi.) (lak)
Mar 28, 2022	N/A	Oral Order (0) Docket Text: ORAL ORDER: The redacted filing (D.I. [380]) is REJECTED because parts of it are redacted in its entirety. Absent a compelling reason, supported by a statement under oath by a party, redactions in their entirety are impermissible; redactions must be done so as to redact the least possible amount of the materials submitted. Failure to make a good faith attempt at such redactions may result in sanctions, the most common of which would be simply unsealing the entire filing. Redacting in its entirety a document that contains publicly available materials is prima facie evidence of bad faith. Revised redacted filing is DUE within five business days. Ordered by Judge Richard G. Andrews on 3/28/2022. (nms)
Mar 25, 2022	379	Redacted Document (30) Docket Text: REDACTED VERSION of [343] Answering Brief in Opposition by Liquidia Technologies, Inc.. (DiBenedetto, Emily)
Mar 25, 2022	380	Redacted Document (10) Docket Text: REDACTED VERSION of [344] Declaration by Liquidia Technologies, Inc.. (DiBenedetto, Emily)
Mar 25, 2022	381	Redacted Document (30) Docket Text: REDACTED VERSION of [345] Declaration, by Liquidia Technologies, Inc.. (DiBenedetto, Emily) Modified on 3/28/2022 (nms).
Mar 24, 2022	378	Letter (1) Docket Text: Letter to Honorable Richard G. Andrews from Michael J. Flynn regarding copies of the requested pictures of plaintiff's witnesses and pages from the expert witnesses' curricula vitae. (Flynn, Michael)
Mar 23, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [376] STIPULATION to Extend Time to File Redacted Filing to March 25, 2022. Signed by Judge Richard G. Andrews on 3/23/2022. (nms)
Mar 22, 2022	372	Redacted Document (11) Docket Text: REDACTED VERSION of [323] MOTION in Limine No. 1 by United Therapeutics Corporation. (Simonetti, Sarah)
Mar 22, 2022	373	Main Document (4) Docket Text: REDACTED VERSION of [324] Sealed Exhibits, by United Therapeutics Corporation. (Attachments: # (1) Exhibits A-D, # (2) Exhibits 1-10)(Simonetti, Sarah) Modified on 3/22/2022 (nms).
Mar 22, 2022	373	Exhibits A-D (89)
Mar 22, 2022	373	Exhibits 1-10 (226)
Mar 22, 2022	374	Memorandum Opinion (8) Docket Text: MEMORANDUM. Signed by Judge Richard G. Andrews on 3/22/2022. (nms)
Mar 22, 2022	375	Order (1) Docket Text: ORDER: Plaintiff's Motion for Presumption Under 35 U.S.C § 295 (D.I. [311]) is DENIED. Signed by Judge Richard G. Andrews on 3/22/2022. (nms)
Mar 22, 2022	376	Stipulation to EXTEND Time (2) Docket Text: STIPULATION to Extend Time to File Redacted Filing to March 25, 2022 - filed by Liquidia Technologies, Inc.. (DiBenedetto, Emily) Modified on 3/23/2022 (nms).
Mar 21, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [366] STIPULATION TO EXTEND TIME to submit proposed public versions of United Therapeutics Corporation's Motion in Limine No. 1 and accompanying exhibits (D.I. 323-324) to March 22, 2022. Signed by Judge Richard G. Andrews on 3/21/2022. (nms)
Mar 21, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [368] MOTION for Pro Hac Vice Appearance of Attorney Ian B. Brooks, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 3/21/2022. (nms)
Mar 21, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [369] MOTION for Pro Hac Vice Appearance of Attorney Eric Levi, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 3/21/2022. (nms)
Mar 21, 2022	367	Transcript (68) Docket Text: Official Transcript of Pretrial Conference held on 3/4/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/11/2022. Redacted Transcript Deadline set for 4/21/2022. Release of Transcript Restriction set for 6/21/2022. (Triozzi, Heather)
Mar 21, 2022	368	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ian B. Brooks - filed by United Therapeutics Corporation. (Flynn, Michael)
Mar 21, 2022	369	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Eric Levi - filed by United Therapeutics Corporation. (Flynn, Michael)
Mar 21, 2022	370	Redacted Document (16) Docket Text: REDACTED VERSION of [352] Reply Brief by United Therapeutics Corporation. (Simonetti, Sarah)
Mar 21, 2022	371	Main Document (4) Docket Text: REDACTED VERSION of [353] Declaration of Michael J. Flynn, by United Therapeutics Corporation. (Attachments: # (1) Exhibits AA-LL, part 1, # (2) Exhibits AA-LL, part 2, # (3) Exhibits AA-LL, part 3)(Simonetti, Sarah) Modified on 3/22/2022 (nms).
Mar 21, 2022	371	Exhibits AA-LL, part 1 (153)
Mar 21, 2022	371	Exhibits AA-LL, part 2 (47)
Mar 21, 2022	371	Exhibits AA-LL, part 3 (42)
Mar 18, 2022	358	Main Document (3) Docket Text: REDACTED VERSION of [333] Exhibit to a Document by United Therapeutics Corporation. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11)(Simonetti, Sarah)
Mar 18, 2022	358	Exhibit 10 (102)
Mar 18, 2022	358	Exhibit 11 (41)
Mar 18, 2022	359	Redacted Document (30) Docket Text: REDACTED VERSION of [332] Exhibit to a Document by Liquidia Technologies, Inc.. (DiBenedetto, Emily)
Mar 18, 2022	360	Report and Recommendations (10) Docket Text: REPORT AND RECOMMENDATION re [281] Defendant's Motion for Summary Judgment of Invalidity of the '066 and '901 Patents due to Collateral Estoppel. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. (*Objections to R&R due by 4/1/2022). Signed by Judge Jennifer L. Hall on 3/18/2022. (ceg)
Mar 18, 2022	361	Redacted Document (11) Docket Text: REDACTED VERSION of [325] MOTION in Limine No. 2 by United Therapeutics Corporation. (Simonetti, Sarah)
Mar 18, 2022	362	Main Document (4) Docket Text: REDACTED VERSION of [326] Exhibit to a Document by United Therapeutics Corporation. (Attachments: # (1) Exhibits A-L, # (2) Exhibits 1-5)(Simonetti, Sarah)
Mar 18, 2022	362	Exhibits A-L (198)
Mar 18, 2022	362	Exhibits 1-5 (50)
Mar 18, 2022	363	Redacted Document (24) Docket Text: REDACTED VERSION of [350] Proposed Pretrial Order by United Therapeutics Corporation. (Simonetti, Sarah)
Mar 18, 2022	364	Redacted Document (30) Docket Text: REDACTED VERSION of [351] Exhibit to a Document by United Therapeutics Corporation. (Simonetti, Sarah)
Mar 18, 2022	365	Redacted Document (30) Docket Text: REDACTED VERSION of [322] Proposed Pretrial Order by United Therapeutics Corporation. (Simonetti, Sarah)
Mar 18, 2022	366	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit proposed public versions of United Therapeutics Corporation's Motion in Limine No. 1 and accompanying exhibits (D.I. 323-324) to March 22, 2022 - filed by United Therapeutics Corporation. (Simonetti, Sarah)
Mar 17, 2022	356	Order (3) Docket Text: SO ORDERED Granting [355] Stipulation and Order. Signed by Judge Richard G. Andrews on 3/17/2022. (nms)
Mar 17, 2022	357	Redacted Document (30) Docket Text: REDACTED VERSION of [348] Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Mar 16, 2022	355	Stipulation (3) Docket Text: STIPULATION [and Proposed Order] regarding evidence of non-infrigment and invalidity of the asserted claims of the '901 patent at trial by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Mar 15, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [354] STIPULATION to Extend Time to submit proposed public versions to March 22, 2022. Signed by Judge Richard G. Andrews on 3/15/2022. (nms)
Mar 15, 2022	354	Stipulation to EXTEND Time (2) Docket Text: STIPULATION to Extend Time to submit proposed public versions to March 22, 2022 - filed by Liquidia Technologies, Inc.. (DiBenedetto, Emily) Modified on 3/15/2022 (nms).
Mar 11, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [347] STIPULATION to Extend Time to submit redacted documents to March 18, 2022. Signed by Judge Richard G. Andrews on 3/11/2022. (nms)
Mar 11, 2022	N/A	Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Telephone Conference held on 3/11/2022. The Court read from the bench its Report & Recommendation on the pending Motion for Summary Judgment. (*Court Reporter Heather Triozzi.) (ceg)
Mar 11, 2022	N/A	Oral Order (0) Docket Text: ORAL ORDER re REPORT AND RECOMMENDATION: For the reasons announced from the bench at today's teleconference, the Court recommends that the pending motion for summary judgment (D.I. [281]) be DENIED. The Court anticipates that it will file on the docket a written document incorporating a transcript of its oral recommendation. ORDERED by Judge Jennifer L. Hall on 3/11/2022. (ceg)
Mar 10, 2022	N/A	Motion Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Motion Hearing held on 3/10/2022 via video conference re [281] Defendant's Motion for Summary Judgment of Invalidity of the '066 and '901 Patents due to Collateral Estoppel. (*Court Reporter Deanna Warner.) (ceg)
Mar 10, 2022	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER: The Motion for Summary Judgment hearing will resume telephonically on Friday, March 11, 2022, at 3:00 PM Eastern Time before Judge Jennifer L. Hall. The parties shall call the Court's conference line at (877) 336-1829, access code: 7090640. ORDERED by Judge Jennifer L. Hall on 3/10/2022. (ceg)
Mar 10, 2022	347	Stipulation to EXTEND Time (2) Docket Text: STIPULATION to Extend Time - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 3/11/2022 (nms).
Mar 8, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [338] STIPULATION to Extend Time to submit proposed public versions of the Joint Proposed Pretrial Order (D.I. 322), as well as motions in limine and accompanying exhibits (D.I. 323-326) to March 18, 2022. Signed by Judge Richard G. Andrews on 3/8/2022. (nms)
Mar 8, 2022	339	Redacted Document (26) Docket Text: REDACTED VERSION of [312] Opening Brief in Support by United Therapeutics Corporation. (Simonetti, Sarah)
Mar 8, 2022	340	Main Document (4) Docket Text: REDACTED VERSION of [313] Declaration by United Therapeutics Corporation. (Attachments: # (1) Exhibits A-Z)(Simonetti, Sarah)
Mar 8, 2022	340	Exhibits A-Z (506)
Mar 8, 2022	341	Main Document (19) Docket Text: REDACTED VERSION of [314] Declaration by United Therapeutics Corporation. (Attachments: # (1) Exhibits 1-7)(Simonetti, Sarah)
Mar 8, 2022	341	Exhibits 1-7 (225)
Mar 8, 2022	342	Redacted Document (7) Docket Text: REDACTED VERSION of [315] Declaration by United Therapeutics Corporation. (Simonetti, Sarah)
Mar 7, 2022	337	Redacted Document (17) Docket Text: REDACTED VERSION of [320] MOTION in Limine to Exclude Portions of Dr. Mahdi Fawzi's Rebuttal Expert Report by Liquidia Technologies, Inc.. (DiBenedetto, Emily)
Mar 7, 2022	338	Stipulation to EXTEND Time (2) Docket Text: STIPULATION to Extend Time to submit proposed public versions of the Joint Proposed Pretrial Order (D.I. 322), as well as motions in limine and accompanying exhibits (D.I. 323-326) to March 18, 2022 - filed by United Therapeutics Corporation. (Simonetti, Sarah) Modified on 3/8/2022 (nms).
Mar 4, 2022	N/A	Pretrial Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Pretrial Conference held on 3/4/2022. Counsel for Plaintiff: M. Flynn. Counsel for Defendant: H. Hoeschen. The parties shall submit a revised pretrial order by the end of next week. A few days before the start of the trial, the parties are directed to provide the Court with binders of the witnesses they intend to call. (Court Reporter Heather Triozzi.) (lak)
Mar 4, 2022	334	Order (2) Docket Text: ORDER AFTER PRETRIAL CONFERENCE: The Proposed Pretrial Order is ADOPTED as modified by any discussion at the pretrial conference. The parties were requested to submit a revised pretrial order by the end of next week. A bench trial will begin on March 28, 2022, at 8:30 a.m. Each party should be prepared to present its case until 5:00 p.m. of each trial day, although the end of the trial day may, in the discretion of the Court, be earlier than 5:00 p.m.. The trial is timed. Each side is allowed 10 hours for its opening statement and its direct and cross-examination of witnesses (see Order for further details). Signed by Judge Richard G. Andrews on 3/4/2022. (nms)
Mar 4, 2022	335	Order (2) Docket Text: ORDER ON MOTION IN LIMINE: Plaintiff's MIL #1 (D.I. [323]) is GRANTED. Plaintiff's MIL #2 (D.I. [325]) is DENIED. Defendant's MIL (D.I. [320]) is GRANTED in part, DENIED in part, and LEFT OPEND in part (see Order for further details). Signed by Judge Richard G. Andrews on 3/4/2022. (nms)
Mar 4, 2022	336	Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Jeffrey T. Castellano as co-counsel.. (Hoeschen, Nathan)
Mar 2, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [329] STIPULATION to Extend Time to submit redacted filings to March 8, 2022. Signed by Judge Richard G. Andrews on 3/2/2022. (nms)
Mar 2, 2022	N/A	Oral Order (0) Docket Text: ORAL ORDER: The Stipulation to Extend Time (D.I. [328]) is DENIED without prejudice, and the parties are given leave to raise the issue at the Pretrial Conference. Ordered by Judge Richard G. Andrews on 3/2/2022. (nms)
Mar 1, 2022	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The exhibits filed on 2/28/2022, at D.I. 321 have been removed from the docket. The filing lacked a proper captioned cover page. Counsel is to refile the exhibits accordingly. (nms)
Mar 1, 2022	N/A	Deficiency Notice (0) Docket Text: DEFICIENCY NOTICE by the Court issued to United Therapeutics Corporation re [323] Sealed Motion in Limine, and [325] Sealed Motion in Limine. Upon review it was determined these sealed filings do not comply with Local Rule 5.2(b)(1). Plaintiff is requested to supplement the docket with an appropriate certificate of service. (nms)
Mar 1, 2022	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for the exhibits found at D.I. [355] has been replaced with a corrected version per the filers request. (nms)
Mar 1, 2022	327	Certificate of Service (3) Docket Text: CERTIFICATE OF SERVICE of (1) Plaintiff's Motion in Limine No. 1 (D.I. 323) and (2) Plaintiff's Motion in Limine No. 2 (D.I. 325) - by United Therapeutics Corporation (Flynn, Michael)
Mar 1, 2022	328	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file an answering brief in opposition to Plaintiffs Motion for Presumption Under 35 U.S.C. § 295 (D.I. 311) to March 11, 2022 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Mar 1, 2022	329	Stipulation to EXTEND Time (2) Docket Text: STIPULATION to Extend Time to submit redacted filings to March 8, 2022 - filed by United Therapeutics Corporation. (Simonetti, Sarah) Modified on 3/2/2022 (nms).
Mar 1, 2022	N/A	Order Setting Hearing on Motion (0) Docket Text: ORAL ORDER re Motion for Summary Judgment: A hearing on the pending Motion for Summary Judgment (D.I. [281]) is scheduled for March 10, 2022 at 2:30 PM via video conference before Judge Jennifer L. Hall. Each side will be allocated 15 minutes for argument. The parties shall send a joint email to Cailah_Garfinkel@ded.uscourts.gov containing the following information regarding oral argument on or before March 8, 2022: (1) a video conference link with instructions on how to join the conference; (2) a separate audio-only dial-in; and (3) a list of attendees for each party, specifying who will be presenting argument. Any video conference must be sufficient to accommodate Judge Hall, the courtroom deputy, a law clerk, and the court reporter. Any slide presentations or demonstratives that the parties wish to use during the hearing shall be emailed to Cailah_Garfinkel@ded.uscourts.gov no later than 24 hours prior to the hearing. Slide presentations or demonstratives may be presented by the parties on the video conference screen or referred to by the parties at the hearing. Once the dial-in information is received by the Court, members of the public may obtain it by contacting Chambers at Cailah_Garfinkel@ded.uscourts.gov. All participants (including any media and members of the public) are reminded that recording or broadcasting proceedings is STRICTLY PROHIBITED. All participants shall be present on the video conference no later than 10 minutes prior to the start of the hearing. The Court may choose to resolve the motion prior to the hearing and will, in that event, cancel the hearing. ORDERED by Judge Jennifer L. Hall on 3/1/2022. (ceg)
Feb 24, 2022	N/A	Motions No Longer Referred (0) Docket Text: Motions No Longer Referred: [311] MOTION for Presumption Under 35 U.S.C § 295. (nms)
Feb 23, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [316] STIPULATION TO EXTEND TIME to file a redacted version of its Opening Discovery Dispute Letter to February 25, 2022. Signed by Judge Richard G. Andrews on 2/23/2022. (nms)
Feb 23, 2022	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdfs for Exhibits 33, 41, 42, and 43 found at D.I. [303] have been replaced with corrected versions. Exhibits 33 and 41 have been amended to reflect typographical errors, and exhibits 42 and 43 have been pared down. Opposing counsel has agreed to the corrections and has been reserved with the exhibits. (nms)
Feb 23, 2022	317	Declaration (6) Docket Text: DECLARATION of Kyung Taeck Minn re [303] Reply Brief, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 2/23/2022 (nms).
Feb 23, 2022	318	Redacted Document (1) Docket Text: REDACTED VERSION of [306] Letter by United Therapeutics Corporation. (Simonetti, Sarah)
Feb 23, 2022	319	Redacted Document (30) Docket Text: REDACTED VERSION of [305] Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Feb 22, 2022	311	Motion for Miscellaneous Relief (6) Docket Text: MOTION for Presumption Under 35 U.S.C § 295 - filed by United Therapeutics Corporation.(Flynn, Michael) Modified on 2/24/2022 (nms).
Feb 22, 2022	316	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to file a redacted version of its Opening Discovery Dispute Letter to February 25, 2022 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Feb 18, 2022	309	Letter (1) Docket Text: Letter to The Honorable Jennifer L. Hall, from Nathan R. Hoeschen, regarding request for oral argument. (Hoeschen, Nathan) Modified on 2/18/2022 (nms).
Feb 18, 2022	310	Redacted Document (30) Docket Text: REDACTED VERSION of [303] Reply Brief, by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Feb 17, 2022	N/A	Oral Order (0) Docket Text: ORAL ORDER: On or before February 23, 2022, counsel should submit to the Clerk's Office (2) courtesy copies of all briefs and (2) copies of any other document filed in support of any briefs (i.e., appendices, exhibits, declarations, affidavits etc.) regarding the pending motion(s) referred to Judge Hall. ORDERED by Judge Jennifer L. Hall on 2/17/2022. (ceg)
Feb 16, 2022	N/A	Order Cancelling Deadline (0) Docket Text: ORAL ORDER: Having reviewed the letters submitted by the parties in connection with the Motion for Teleconference Regarding Discovery Dispute (D.I. [301], [305], [306]), it is ORDERED that Liquidia's request is denied as moot. The teleconference scheduled for February 17, 2022 is CANCELLED. ORDERED by Judge Jennifer L. Hall on 2/16/2022. (ceg)
Feb 14, 2022	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Exhibit 44 has been added to the brief filed at D.I. [303] as it was inadvertently omitted at the initial time of filing. Defendant has confirmed the exhibit has been served on Plaintiff. (nms)
Feb 14, 2022	N/A	Order Referring Motion (0) Docket Text: ORAL ORDER: The Motion for Summary Judgment of Invalidity of the '066 and '901 Patents due to Collateral Estoppel (D.I. [281]) is now REFFERED to Magistrate Judge Jennifer L. Hall. Ordered by Judge Richard G. Andrews on 2/14/2022. Motions referred to Jennifer L. Hall.(nms)
Feb 11, 2022	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. [301]). A discovery dispute teleconference is scheduled for February 17, 2022 at 12:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than COB on February 14, 2022, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than noon on February 16, 2022, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 2/11/2022. (ceg)
Feb 9, 2022	300	Notice Requesting Removal of Co-Counsel (4) Docket Text: NOTICE requesting Clerk to remove Joel Broussard as co-counsel. Reason for request: no longer with the firm. (Flynn, Michael)
Feb 9, 2022	301	Motion for Miscellaneous Relief (2) Docket Text: MOTION for Teleconference regarding Discovery Dispute - filed by Liquidia Technologies, Inc.. Motions referred to Jennifer L. Hall.(Hoeschen, Nathan)
Feb 8, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [299] MOTION for Pro Hac Vice Appearance of Attorney Kyung Taeck Minn, filed by Liquidia Technologies, Inc.. Signed by Judge Richard G. Andrews on 2/8/2022. (nms)
Feb 8, 2022	299	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kyung Taeck Minn - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Feb 4, 2022	295	Redacted Document (28) Docket Text: REDACTED VERSION of [290] Answering Brief in Opposition, by United Therapeutics Corporation. (Simonetti, Sarah)
Feb 4, 2022	296	Redacted Document (30) Docket Text: REDACTED VERSION of [291] Declaration by United Therapeutics Corporation. (Simonetti, Sarah)
Feb 4, 2022	297	Redacted Document (9) Docket Text: REDACTED VERSION of [292] Declaration by United Therapeutics Corporation. (Simonetti, Sarah)
Feb 4, 2022	298	Main Document (5) Docket Text: REDACTED VERSION of [293] Declaration by United Therapeutics Corporation. (Attachments: # (1) Exhibit 1-14)(Simonetti, Sarah)
Feb 4, 2022	298	Exhibit 1-14 (379)
Jan 31, 2022	294	Order (5) Docket Text: SO ORDERED Granting [288] Stipulation and Proposed Order for Pretrial Exchanges. Signed by Judge Richard G. Andrews on 1/31/2022. (nms)
Jan 28, 2022	288	Stipulation (5) Docket Text: STIPULATION and [Proposed] Order for Pretrial Exchanges - by United Therapeutics Corporation. (Flynn, Michael)
Jan 28, 2022	289	Redacted Document (30) Docket Text: REDACTED VERSION of [282] Opening Brief in Support, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 1/31/2022 (nms).
Jan 24, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [287] STIPULATION TO EXTEND TIME to file a redacted version of its Opening Brief in Support of its Motion for Summary Judgment (D.I. 282) to January 28, 2022. Signed by Judge Richard G. Andrews on 1/24/2022. (nms)
Jan 21, 2022	287	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendant Liquidia Technologies, Inc. to file a redacted version of its Opening Brief in Support of its Motion for Summary Judgment (D.I. 282) to January 28, 2022 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Jan 14, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [284] STIPULATION TO EXTEND TIME to take the depositions of Plaintiff's expert witnesses Cesar Matto and Hugh Smyth to January 21, 2022, and January 19, 2022, respectively. Signed by Judge Richard G. Andrews on 1/14/2022. (nms)
Jan 14, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [285] STIPULATION TO EXTEND TIME to file a redacted version of Opening Brief in Support of its Motion for Summary Judgment (D.I. 282) to January 21, 2022. Signed by Judge Richard G. Andrews on 1/14/2022. (nms)
Jan 14, 2022	284	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to take the depositions of Plaintiff's expert witnesses Cesar Matto and Hugh Smyth to January 21, 2022, and January 19, 2022, respectively - filed by United Therapeutics Corporation. (Flynn, Michael)
Jan 14, 2022	285	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendant Liquidia Technologies, Inc. to file a redacted version of its Opening Brief in Support of its Motion for Summary Judgment (D.I. 282) to January 21, 2022 - filed by United Therapeutics Corporation. (Flynn, Michael)
Jan 14, 2022	286	Transcript (36) Docket Text: Official Transcript of Discovery Conference held on 12/6/21 before Judge Jennifer L. Hall. Court Reporter Deanna Warner,Email: Warnerdeanna@gmail.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/4/2022. Redacted Transcript Deadline set for 2/14/2022. Release of Transcript Restriction set for 4/14/2022. (Triozzi, Heather)
Jan 13, 2022	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Adam M. Pivovar for Liquidia Technologies, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Jan 11, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [283] STIPULATION to Extend Time (*Reset Briefing Schedule: re [281] MOTION for Summary Judgment of Invalidity of the '066 and '901 Patents due to Collateral Estoppel. Answering Brief due 1/28/2022, Reply Brief due 2/11/2022). Signed by Judge Richard G. Andrews on 1/11/2022. (nms)
Jan 11, 2022	283	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME - (1) for Plaintiff United Therapeutics Corporation to file its response to Defendant Liquidia Technologies, Inc.'s Motion for Summary Judgment (D.I. 281) and (2) for Liquidia to file its reply brief to January 28, 2022 and February 11, 2022, respectively - filed by United Therapeutics Corporation. (Flynn, Michael)
Jan 7, 2022	281	Main Document (2) Docket Text: MOTION for Summary Judgment of Invalidity of the '066 and '901 Patents due to Collateral Estoppel - filed by Liquidia Technologies, Inc.. (Attachments: # (1) Proposed Order)(Keller, Karen) Modified on 1/7/2022 (nms).
Jan 7, 2022	281	Text of Proposed Order (1)
Jan 5, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [280] MOTION for Pro Hac Vice Appearance of Attorney Adam Pivovar, filed by Liquidia Technologies, Inc.. Signed by Judge Richard G. Andrews on 1/5/2022. (nms)
Jan 5, 2022	280	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Adam Pivovar - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Jan 3, 2022	278	Order (5) Docket Text: SO ORDERED Granting [276] Stipulation of Partial Judgment of Non-Infringement. Signed by Judge Richard G. Andrews on 1/3/2022. (nms)
Dec 28, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [277] MOTION for Pro Hac Vice Appearance of Attorney Mandy H. Kim, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 12/28/2021. (nms)
Dec 28, 2021	276	Stipulation (5) Docket Text: STIPULATION of Partial Judgment of Non-Infringement by United Therapeutics Corporation. (Flynn, Michael)
Dec 28, 2021	277	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Mandy H. Kim - filed by United Therapeutics Corporation. (Flynn, Michael)
Dec 27, 2021	275	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Supplemental Rebuttal Expert Report of Dr. Jeffrey Winkler on the Issue of Non-Infringement and Addressing the Supplemental Opening Expert Report of Dr. Toste filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Dec 21, 2021	273	Redacted Document (30) Docket Text: REDACTED VERSION of [257] Reply Brief by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Dec 21, 2021	274	Redacted Document (30) Docket Text: REDACTED VERSION of [265] Letter by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Dec 20, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [272] STIPULATION to Extend Time to submit a public version of Reply Brief (D.I. 257) to December 21, 2021. Signed by Judge Richard G. Andrews on 12/20/2021. (nms)
Dec 17, 2021	272	Stipulation to EXTEND Time (1) Docket Text: STIPULATION to Extend Time to submit a public version of Reply Brief (D.I. 257) to December 21, 2021 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 12/20/2021 (nms). Modified on 12/20/2021 (nms).
Dec 16, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [270] STIPULATION TO EXTEND TIME to submit a proposed public version of letter (D.I. [255]) to December 16, 2021. Signed by Judge Richard G. Andrews on 12/16/2021. (nms)
Dec 16, 2021	271	Main Document (5) Docket Text: REDACTED VERSION of [255] Letter by United Therapeutics Corporation. (Attachments: # (1) Exhibit 1-6)(Simonetti, Sarah)
Dec 16, 2021	271	Exhibit 1-6 (544)
Dec 15, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [269] STIPULATION to Extend Time to submit a proposed public version of Reply Brief (D.I. [257]) to December 17, 2021. Signed by Judge Richard G. Andrews on 12/15/2021. (nms)
Dec 15, 2021	270	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed public version of United Therapeutics Corporation's Letter in Response to Liquidia Technology Inc.'s December 2, 2021 Letter to December 16, 2021 - filed by United Therapeutics Corporation. (Simonetti, Sarah)
Dec 14, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [263] STIPULATION TO EXTEND TIME to submit a proposed public version to December 15, 2021. Signed by Judge Richard G. Andrews on 12/14/2021. (nms)
Dec 14, 2021	N/A	Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery Dispute Teleconference held on 12/14/2021. (*Court Reporter Deanna Warner.) (ceg)
Dec 14, 2021	266	Main Document (3) Docket Text: Letter to The Honorable Jennifer L. Hall, from Michael Flynn, regarding scope of the deposition of Dr. Seeger. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Flynn, Michael)
Dec 14, 2021	266	Ex. 1 (13)
Dec 14, 2021	266	Ex. 2 (4)
Dec 14, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER: Liquidias Motion for Leave to Move for Summary Judgment (D.I. [224]) is GRANTED-IN-PART and DENIED-IN-PART. The Court grants Liquidia leave to move for summary judgment of invalidity of the 066 patent and 901 patent due to collateral estoppel and denies leave to move for summary judgment of invalidity of the 901 patent as obvious. Liquidias motion and brief are due on January 7, 2022. Ordered by Judge Richard G. Andrews on 12/14/2021. (nms)
Dec 14, 2021	N/A	Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the December 14, 2021 discovery dispute teleconference shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 12/14/2021. (ceg)
Dec 14, 2021	269	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed public version of Liquidia Technologies, Inc.'s Reply Brief in Support of its Motion for Leave (D.I. 257) to December 17, 2021 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Dec 13, 2021	261	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Pilar Wyman on December 16, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Dec 13, 2021	262	Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1. Expert Report of Omar Robles, Ph.D.; 2. Reply Expert Report of Dr. Igor Gonda; 3. Reply Expert Report of Dr. Jeffrey Winkler; 4.Reply Expert Report of Dr. Nicholas Hill Regarding Invalidity of U.S. Patent No. 10,716,793; and 5. Expert Report of Dr. Sylvia Hall-Ellis Addressing the Rebuttal Expert Report of Ms. Pilar Wyman filed by Liquidia Technologies, Inc..(Keller, Karen)
Dec 13, 2021	263	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed public version of United Therapeutics Corporation's Letter in Response to Liquidia Technology Inc.'s December 2, 2021 Letter to December 15, 2021 - filed by United Therapeutics Corporation. (Simonetti, Sarah)
Dec 13, 2021	264	Redacted Document (30) Docket Text: REDACTED VERSION of [254] Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Dec 10, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [258] STIPULATION TO EXTEND TIME to submit proposed public versions of the parties respective discovery dispute letters (D.I. 254 and 255) to December 13, 2021. Signed by Judge Richard G. Andrews on 12/10/2021. (nms)
Dec 10, 2021	259	Motion for Hearing (2) Docket Text: MOTION for Teleconference to Resolve Discovery Dispute - filed by United Therapeutics Corporation. Motions referred to Jennifer L. Hall.(Flynn, Michael) Modified on 12/10/2021 (ceg).
Dec 10, 2021	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. [259]). A discovery dispute teleconference is scheduled for December 14, 2021 at 4:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than December 14, 2021, at 12:00 PM Eastern Time, the parties shall simultaneously file a one page letter brief with no responsive letter briefs. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 12/10/2021. (ceg)
Dec 9, 2021	258	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit proposed public versions of the parties respective discovery dispute letters (D.I. 254 and 255) to December 13, 2021 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Dec 7, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the December 6, 2021 discovery dispute teleconference shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 12/6/2021. (ceg)
Dec 6, 2021	N/A	Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery Dispute Teleconference held on 12/6/2021. (*Court Reporter Deanna Warner.) (ceg)
Dec 1, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [251] STIPULATION TO EXTEND TIME to submit a proposed public version to December 2, 2021. Signed by Judge Richard G. Andrews on 12/1/2021. (nms)
Dec 1, 2021	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the Joint Motion for Teleconference to Resolve Discovery Dispute (D.I. [250]). A discovery dispute teleconference is scheduled for December 6, 2021 at 4:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than December 2, 2021 the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than December 3, 2021 any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 12/1/2021. (ceg)
Dec 1, 2021	253	Main Document (25) Docket Text: REDACTED VERSION of [246] Answering Brief in Opposition, by United Therapeutics Corporation. (Attachments: # (1) Exhibit 1-5)(Simonetti, Sarah)
Dec 1, 2021	253	Exhibit 1-5 (162)
Nov 30, 2021	251	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed public versions - filed by United Therapeutics Corporation. (Simonetti, Sarah) Modified on 12/1/2021 (nms).
Nov 29, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [249] STIPULATION TO EXTEND TIME to file a reply brief (*Reset Briefing Schedule: re [224] MOTION for Leave to Move for Summary Judgment. Reply Brief due 12/7/2021). Signed by Judge Richard G. Andrews on 11/29/2021. (nms)
Nov 29, 2021	249	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for defendant Liquidia Technologies, Inc. to file a reply brief in support of its Motion for Leave to Move for Summary Judgment (D.I. 224) to December 7, 2021 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Nov 29, 2021	250	Motion for Miscellaneous Relief (3) Docket Text: MOTION for Teleconference to Resolve Discovery Dispute - filed by Liquidia Technologies, Inc.. Motions referred to Jennifer L. Hall.(Hoeschen, Nathan)
Nov 24, 2021	248	Redacted Document (30) Docket Text: REDACTED VERSION of [237] Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Nov 23, 2021	243	Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Werner Seeger on December 17, 2021 filed by United Therapeutics Corporation.(Flynn, Michael)
Nov 23, 2021	244	Proposed Order (1) Docket Text: PROPOSED Claim Construction Order, by United Therapeutics Corporation. (Flynn, Michael) Modified on 11/23/2021 (nms).
Nov 23, 2021	245	Order (1) Docket Text: CLAIM CONSTRUCTION ORDER. Signed by Judge Richard G. Andrews on 11/23/2021. (nms)
Nov 23, 2021	247	Main Document (4) Docket Text: REDACTED VERSION of [235] Letter by United Therapeutics Corporation. (Attachments: # (1) Exhibit A-C)(Flynn, Michael)
Nov 23, 2021	247	Exhibit A-C (26)
Nov 19, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, [239] Stipulation to Extend Time to submit a proposed public version of Liquidia Technologies, Inc.'s discovery dispute letter to November 18, 2021. ORDERED by Judge Jennifer L. Hall on 11/19/2021. (ceg)
Nov 18, 2021	N/A	Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery Dispute Teleconference held on 11/18/2021. (*Court Reporter Heather Triozzi.) (ceg)
Nov 18, 2021	240	Redacted Document (30) Docket Text: REDACTED VERSION of [226] Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Nov 18, 2021	241	Memorandum Opinion (10) Docket Text: MEMORANDUM OPINION providing claim construction for multiple terms in U.S. Patent No. 9,593,066 and U.S. Patent No.9,604,901. Within five days the parties shall submit a proposed order consistent with this Memorandum Opinion. Signed by Judge Richard G. Andrews on 11/18/2021. (nms)
Nov 18, 2021	N/A	Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the November 18, 2021 discovery dispute teleconference shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 11/18/2021. (ceg)
Nov 17, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [236] STIPULATION to Extend Time (*Reset Briefing Schedule: re [224] MOTION for Leave to Move for Summary Judgment. Answering Brief due 11/23/2021). Signed by Judge Richard G. Andrews on 11/17/2021. (nms)
Nov 17, 2021	236	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Plaintiff United Therapeutics Corporation to file its Answering Brief in Opposition to Defendant Liquidia Technologies, Inc.'s Motion for Leave to Move for Summary Judgment (D.I. 224) to November 23, 2021 - filed by United Therapeutics Corporation. (Flynn, Michael)
Nov 17, 2021	238	Order (2) Docket Text: ORDER: Plaintiff's Motion for Leave to File a Second Amended Complaint (D.I. [109]) is DENIED. Signed by Judge Richard G. Andrews on 11/17/2021. (nms)
Nov 17, 2021	239	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed public version of Liquidia Technologies, Inc.'s discovery dispute letter to November 18, 2021 - filed by United Therapeutics Corporation. (Simonetti, Sarah)
Nov 15, 2021	234	Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1. Rebuttal Expert Report of John Fusion Addressing the Expert Report of Cesar Matto 2. Rebuttal Expert Report of Dr. Nicholas Hill in Response to the Initial Expert Reports of Dr. Aaron Waxman and Dr. Andrew Clark 3. Rebuttal Expert Report of Dr. Jeffrey Winkler on the Issue of Non-Infringement and Addressing the Expert Reports of Drs. Nuckolls and Toste. filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Nov 12, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for D.I. 228 has been replaced per counsel's request. The NEF for the filing has been regenerated. (nms)
Nov 12, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, [231] Stipulation to Extend Time to submit a proposed public version of Liquidia Technologies, Inc.'s discovery dispute letter (D.I. 226) to November 17, 2021. ORDERED by Judge Jennifer L. Hall on 11/12/2021. (ceg)
Nov 12, 2021	232	Motion for Hearing (2) Docket Text: MOTION for Teleconference to Resolve Discovery Dispute Related to Plaintiff's Subpoena to LGM Pharma, LLC - filed by United Therapeutics Corporation. Motions referred to Jennifer L. Hall.(Flynn, Michael) Modified on 11/12/2021 (nms).
Nov 12, 2021	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. [232]). A discovery dispute teleconference is scheduled for November 18, 2021 at 4:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than November 15, 2021 the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than November 17, 2021 any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 11/12/2021. (ceg)
Nov 10, 2021	231	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed public version of Liquidia Technologies, Inc.'s discovery dispute letter (D.I. 226) to November 17, 2021 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Nov 9, 2021	N/A	Redaction Notice (0) Docket Text: REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of D.I. # [222]. (ceg)
Nov 9, 2021	228	Redacted Document (30) Docket Text: REDACTED VERSION of [225] Opening Brief in Support, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Main Document 228 replaced on 11/12/2021) (nms).
Nov 9, 2021	229	Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove David M. Fry as co-counsel.. (Keller, Karen)
Nov 9, 2021	230	Main Document (4) Docket Text: REDACTED VERSION of [222] Letter by United Therapeutics Corporation. (Attachments: # (1) Exhibit 1-3)(Simonetti, Sarah)
Nov 9, 2021	230	Exhibit 1-3 (594)
Nov 4, 2021	N/A	Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery Dispute Teleconference held on 11/4/2021. (*Court Reporter Stacy Ingram.) (ceg)
Nov 4, 2021	N/A	Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the November 4, 2021 discovery dispute teleconference shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 11/4/2021. (ceg)
Nov 2, 2021	223	Letter (1) Docket Text: Letter to The Honorable Jennifer L. Hall from Michael J. Flynn regarding Deposition of Patrick Poisson. (Flynn, Michael)
Nov 2, 2021	224	Main Document (2) Docket Text: MOTION for Leave to Move for Summary Judgment - filed by Liquidia Technologies, Inc.. (Attachments: # (1) Proposed Order)(Hoeschen, Nathan) Modified on 11/2/2021 (nms).
Nov 2, 2021	224	Text of Proposed Order (1)
Oct 29, 2021	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Expert Discovery Dispute (D.I. [219]). A discovery dispute teleconference is scheduled for November 4, 2021 at 4:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than November 1, 2021 the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than November 3, 2021, at 12:00 p.m. Eastern Time, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 10/29/2021. (ceg)
Oct 27, 2021	219	Motion for Miscellaneous Relief (2) Docket Text: MOTION for Teleconference to Resolve Expert Discovery Dispute - filed by United Therapeutics Corporation. Motions referred to Jennifer L. Hall.(Flynn, Michael)
Oct 27, 2021	220	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s First Supplemental Responses to Plaintiff United Therapeutics Corporation's Third Set of Interrogatories (Nos. 11-12) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Oct 22, 2021	218	Main Document (4) Docket Text: REDACTED VERSION of [207] Letter, by United Therapeutics Corporation. (Attachments: # (1) Exhibits 1-11, # (2) Exhibits 12-15)(Flynn, Michael) Modified on 10/22/2021 (nms).
Oct 22, 2021	218	Exs. 1-11 (444)
Oct 22, 2021	218	Exs. 12-15 (69)
Oct 21, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [216] STIPULATION TO EXTEND TIME to submit proposed public versions of discovery dispute letters to October 21, 2021. Signed by Judge Richard G. Andrews on 10/21/2021. (nms)
Oct 21, 2021	217	Redacted Document (30) Docket Text: REDACTED VERSION of [208] Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Oct 20, 2021	216	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit proposed public versions of the parties' respective discovery dispute letters (D.I. 207 and 208) to October 21, 2021 - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Oct 19, 2021	214	Redacted Document (30) Docket Text: REDACTED VERSION of [206] Letter by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Oct 19, 2021	215	Notice (Other) (30) Docket Text: NOTICE of Response to Request for International Judicial Assistance by United Therapeutics Corporation (Flynn, Michael)
Oct 18, 2021	213	Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Initial Expert Report of Andrew Clark, Ph.D., (2) Initial Expert Report of Colin Nuckolls, Ph.D., (3) Expert Report of Cesar Matto, (4) Initial Expert Report of Aaron Waxman, M.D., Ph.D., and (5) Expert Report of F. Dean Toste, Ph.D. on Infringement of U.S. Patent No. 9,593,066 - filed by United Therapeutics Corporation.(Flynn, Michael)
Oct 15, 2021	211	Redacted Document (2) Docket Text: REDACTED VERSION of [202] Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 10/15/2021 (nms).
Oct 15, 2021	212	Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1. Expert Report of Dr. Igor Gonda 2. Expert Report of Dr. Nicholas Hill 3. Opening Expert Report of Dr. Jeffrey Winkler filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Oct 14, 2021	N/A	Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery/Protective Order Dispute Teleconference held on 10/14/2021. (*Court Reporter Stacy Ingram.) (ceg)
Oct 14, 2021	N/A	Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the October 14, 2021 discovery/protective order dispute teleconference shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 10/14/2021. (ceg)
Oct 14, 2021	210	Redacted Document (30) Docket Text: REDACTED VERSION of [201] Letter by United Therapeutics Corporation. (Flynn, Michael)
Oct 13, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for the letter at D.I. [208] has been replaced per counsel's request. The NEF for the filing has been regenerated. (ceg)
Oct 12, 2021	203	Motion for Hearing (2) Docket Text: MOTION for Teleconference to Resolve Protective Order Dispute - filed by United Therapeutics Corporation. Motions referred to Jennifer L. Hall.(Flynn, Michael) Modified on 10/12/2021 (nms).
Oct 12, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER: The pending Motion for Teleconference to Resolve Protective Order Dispute (D.I. [203]) will be heard at the currently scheduled October 14, 2021 teleconference. By no later than today, October 12, 2021, at 6:00 pm, the party(ies) seeking relief shall file with the Court a letter, not to exceed two pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than October 13, 2021, at 3:00 pm, any party(ies) opposing the application for relief may file a letter, not to exceed two pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. ORDERED by Judge Jennifer L. Hall on 10/12/2021. (ceg)
Oct 12, 2021	205	Main Document (4) Docket Text: NOTICE of Supplemental Authority by Liquidia Technologies, Inc. (Attachments: # (1) Exhibit 1)(Hoeschen, Nathan)
Oct 12, 2021	205	Exhibit 1 (65)
Oct 6, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for the Redacted Letter at D.I. [199] has been replaced with a corrected version per counsel's request. (ceg)
Oct 6, 2021	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. [197]). A discovery dispute teleconference is scheduled for October 14, 2021 at 2:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than October 8, 2021 the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than October 12, 2021 any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 10/6/2021. (ceg)
Oct 5, 2021	198	Redacted Document (30) Docket Text: REDACTED VERSION of [182] Letter, by United Therapeutics Corporation. (Flynn, Michael) Modified on 10/5/2021 (nms).
Oct 5, 2021	199	Redacted Document (30) Docket Text: REDACTED VERSION of [180] Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) (Main Document 199 replaced on 10/6/2021) (ceg).
Oct 4, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time to file a joint status letter pursuant to the Court's order to October 8, 2021. (195 in 1:20-cv-00755-RGA-JLH, 10 in 1:21-mc-00377-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 10/4/2021. Associated Cases: 1:20-cv-00755-RGA-JLH, 1:21-mc-00377-RGA-JLH(ceg)
Oct 4, 2021	196	Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Todd Battistoni on October 7, 2021 filed by United Therapeutics Corporation.(Flynn, Michael)
Oct 4, 2021	197	Motion for Miscellaneous Relief (2) Docket Text: MOTION for Teleconference to Resolve Discovery Dispute - filed by United Therapeutics Corporation. Motions referred to Jennifer L. Hall.(Flynn, Michael)
Oct 1, 2021	195	Stipulation to EXTEND Time (2) Docket Text: STIPULATION to Extend Time to file a joint status letter pursuant to the Court's order to October 8, 2021 - filed by United Therapeutics Corporation. (Flynn, Michael)
Sep 29, 2021	194	Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1. Defendant Liquidia Technologies, Inc.'s First Supplemental Objections and Responses to Plaintiff's Second Set of Interrogatories (Nos. 2-10) 2. Defendant Liquidia Technologies, Inc.'s First Supplemental Invalidity Contentions filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Sep 28, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER: The redacted filings (D.I. [189] and [191]) are REJECTED because parts of them are redacted in their entirety. Absent a compelling reason, supported by a statement under oath by a party, redactions in their entirety are impermissible; redactions must be done so as to redact the least possible amount of the materials submitted. Failure to make a good faith attempt at such redactions may result in sanctions, the most common of which would be simply unsealing the entire filing. Redacting in its entirety a document that contains publicly available materials is prima facie evidence of bad faith. Revised redacted filings are DUE within five business days. Ordered by Judge Richard G. Andrews on 9/28/2021. (nms)
Sep 28, 2021	193	Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) United Therapeutics Corporation's Supplemental Objections and Responses to Defendant's Second Set of Interrogatories (Nos. 8-13) and Fourth Set of Interrogatories (Nos. 15-16), (2) United Therapeutics Corporation's Supplemental Objections and Responses to Defendant's First Set of Interrogatories (Nos. 1-7) and (3) Plaintiff United Therapeutics Corporation's Supplemental Infringement Contentions - filed by United Therapeutics Corporation.(Flynn, Michael)
Sep 27, 2021	189	Redacted Document (30) Docket Text: REDACTED VERSION of [180] Letter, by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Sep 27, 2021	190	Redacted Document (30) Docket Text: REDACTED VERSION of [181] Letter - by United Therapeutics Corporation. (Flynn, Michael)
Sep 27, 2021	191	Redacted Document (10) Docket Text: REDACTED VERSION of [182] Letter, by United Therapeutics Corporation. (Flynn, Michael) Modified on 9/28/2021 (nms).
Sep 24, 2021	188	Main Document (5) Docket Text: REDACTED VERSION of [179] Letter by United Therapeutics Corporation. (Attachments: # (1) Exhibit A-D)(Flynn, Michael)
Sep 24, 2021	188	Exhibit A-D (77)
Sep 23, 2021	N/A	Order (0) Docket Text: ORAL ORDER: For the reasons stated in open court on September 22, 2021, the Joint Motion for Teleconference to Resolve Discovery Dispute (C.A. No. 20-755, D.I. 170) and Non-Party LGM Pharma's Motion to Quash Subpoenas (C.A. No. 21-325, D.I. 1) are GRANTED IN PART and DENIED IN PART. The transcript of the September 22, 2021 combined discovery dispute teleconference shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 9/23/2021. Associated Cases: 1:20-cv-00755-RGA-JLH, 1:21-mc-00325-RGA(ceg)
Sep 23, 2021	185	Redacted Document (30) Docket Text: REDACTED VERSION of [177] Letter, by LGM Pharma, LLC, Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 9/24/2021 (nms).
Sep 23, 2021	186	Redacted Document (30) Docket Text: REDACTED VERSION of [178] Letter by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Sep 23, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER: Having been referred non-party Dr. Roscigno's Motion to Partially Quash Subpoenas (C.A. No. 21-mc-377, D.I. 1), IT IS HEREBY ORDERED that Liquidia and UTC (collectively "the parties") and non-party Dr. Roscigno shall meet and confer regarding whether the subpoena requests can and should be narrowed. The parties and Dr. Roscigno shall file a joint status letter on or before October 1, 2021 that sets forth their respective positions on any issues remaining in dispute. The letter shall not exceed six pages, and shall be in no less than 12-point font. Counsel is reminded to provide courtesy copies. The Court may thereafter order a teleconference. ORDERED by Judge Jennifer L. Hall on 9/23/2021. Associated Cases: 1:21-mc-00377-RGA-JLH, 1:20-cv-00755-RGA-JLH(ceg)
Sep 22, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [183] MOTION for Pro Hac Vice Appearance of Attorney Amy Mahan, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 9/22/2021. (nms)
Sep 22, 2021	N/A	Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Combined Discovery Dispute Teleconference held on 9/22/2021 re Joint Motion for Teleconference to Resolve Discovery Dispute (C.A. No. 20-755, D.I. 170) and Non-Party LGM Pharmas Motion to Quash Subpoenas (C.A. No. 21-325, D.I. 1). (*Court Reporter Jennifer Guy.) Associated Cases: 1:20-cv-00755-RGA-JLH, 1:21-mc-00325-RGA(ceg)
Sep 22, 2021	183	Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Amy Mahan - filed by United Therapeutics Corporation. (Flynn, Michael)
Sep 16, 2021	176	Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1. Defendant Liquidia Technologies, Inc.'s Responses and Objections to Plaintiff's First Set of Requests for Admissions (Nos. 1-20) 2. Defendant Liquidia Technologies, Inc.'s Responses and Objections to Plaintiff's Third Set of Requests for Production of Documents (Nos. 78-88) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Sep 15, 2021	174	Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Responses and Objections to Defendant's Second Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 81-82), (2) Plaintiff's Responses and Objections to Defendant's First Set of Requests for Admission to Plaintiff (Nos. 1-14) and (3) United Therapeutics Corporation's Objections and Responses to Defendant's Sixth Set of Interrogatories (Nos. 20-21) - filed by United Therapeutics Corporation.(Flynn, Michael)
Sep 15, 2021	175	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Patrick Poisson on October 5, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Sep 14, 2021	173	Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendant Liquidia Technologies, Inc.'s Responses to Plaintiff United Therapeutics Corporation's Fourth Set of Interrogatories (Nos. 13-14) (2) Defendant Liquidia Technologies, Inc.'s Responses to Plaintiff United Therapeutics Corporation's Fourth [Sic-Fifth] Set of Interrogatories (Nos. 15-20) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Sep 13, 2021	170	Motion for Hearing (2) Docket Text: Joint MOTION for Teleconference to Resolve Discovery Dispute - filed by United Therapeutics Corporation. Motions referred to Jennifer L. Hall.(Flynn, Michael) Modified on 9/13/2021 (ceg).
Sep 13, 2021	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: Pending before the Court are the Joint Motion for Teleconference to Resolve Discovery Dispute (C.A. No. 20-755, D.I. 170) and Non-Party LGM Pharmas Motion to Quash Subpoenas (C.A. No. 21-325, D.I. 1). A combined discovery dispute teleconference is scheduled for September 22, 2021 at 2:00 PM Eastern Time before Judge Jennifer L. Hall. Briefing on the Motion to Quash shall occur in accordance with Judge Hall's standard discovery dispute procedures; the Court will not consider briefs previously filed. By no later than September 16, 2021, each party seeking relief in each dispute shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than September 20, 2021, any parties opposing each application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 9/13/2021. Associated Cases: 1:20-cv-00755-RGA-JLH, 1:21-mc-00325-RGA(ceg)
Sep 13, 2021	172	Notice of Service (5) Docket Text: NOTICE OF SERVICE of United Therapeutics Corporation's Objections and Responses to Defendant's Fifth Set of Interrogatories (Nos. 17-19) - filed by United Therapeutics Corporation.(Flynn, Michael)
Sep 8, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [169] MOTION for Pro Hac Vice Appearance of Attorney Huiya Wu, Joel Broussard and Harrison Gunn, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 9/8/2021. (nms)
Sep 7, 2021	169	Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Huiya Wu, Joel Broussard and Harrison Gunn - filed by United Therapeutics Corporation. (Flynn, Michael)
Sep 3, 2021	168	Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of Dr. Robert Roscigno on September 17, 2021 filed by Liquidia Technologies, Inc..(Keller, Karen)
Aug 31, 2021	167	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Objections and Responses to Plaintiff United Therapeutics Corporation's Notice of 30(b)(6) Deposition filed by Liquidia Technologies, Inc..(Keller, Karen)
Aug 30, 2021	166	Notice of Service (5) Docket Text: NOTICE OF SERVICE of United Therapeutics Corporation's Responses and Objections to Liquidia Technologies, Inc.'s Rule 30(B)(6) Notice of Deposition - filed by United Therapeutics Corporation.(Flynn, Michael)
Aug 26, 2021	165	Redacted Document (13) Docket Text: REDACTED VERSION of [162] Notice to Take Deposition by United Therapeutics Corporation. (Flynn, Michael)
Aug 18, 2021	161	Transcript (147) Docket Text: Official Transcript of Markman Hearing held on 6/4/21 before Judge Richard G. Andrews. Court Reporter Patrick O'Hare,Email: rebecca.laurenzi@lexitaslegal.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/8/2021. Redacted Transcript Deadline set for 9/20/2021. Release of Transcript Restriction set for 11/16/2021. (Triozzi, Heather)
Aug 18, 2021	163	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiff's Third Set of Requests for Production of Documents to Liquidia Technologies, Inc. (78-88) - filed by United Therapeutics Corporation.(Flynn, Michael)
Aug 18, 2021	164	Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Plaintiff United Therapeutics Corporation's Fourth Set of Interrogatories to Liquidia Technologies, Inc. (Nos. 15-20) and (2) Plaintiff's Requests for Admission to Liquidia Technologies, Inc. (Set 1) - filed by United Therapeutics Corporation.(Flynn, Michael)
Aug 16, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Notice of Service filed at D.I. 157 has been removed from the docket. The filing was incompletely formatted. The first page of the filing was counsel's signature. No where could it be found a captioned cover page or a description of what was actually being served. (nms)
Aug 16, 2021	159	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiff United Therapeutics Corporation's Fourth Set of Interrogatories to Liquidia Technologies, Inc. (Nos. 13-14) - filed by United Therapeutics Corporation.(Flynn, Michael)
Aug 16, 2021	160	Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1. Defendant Liquidia Technologies, Inc.'s Responses and Objections to Plaintiff United Therapeutics Corporation's Third Set of Interrogatories (Nos. 11-12) 2. Defendant's Second Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 81-82) 3. Defendant Liquidia Technologies, Inc.'s Sixth Set of Interrogatories to Plaintiff (Nos. 20-21) 4. Defendant Liquidia Technologies, Inc.'s First Set of Requests for Admissions to Plaintiff United Therapeutics Corporation (Nos. 1-14) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Aug 13, 2021	158	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Fifth Set of Interrogatories to Plaintiff (Nos. 17-19) filed by Liquidia Technologies, Inc..(Keller, Karen)
Aug 11, 2021	154	Proposed Order (2) Docket Text: Stipulated Amendment to the Protective Order, by United Therapeutics Corporation. (Flynn, Michael) Modified on 8/11/2021 (nms).
Aug 11, 2021	155	Notice (Other) (12) Docket Text: NOTICE of Subpoenas as to Lewis J. Rubin by Liquidia Technologies, Inc. (Hoeschen, Nathan)
Aug 11, 2021	156	Order (2) Docket Text: SO ORDERED Granting [154] Stipulated Amendment to the Protective Order. Signed by Judge Richard G. Andrews on 8/11/2021. (nms)
Aug 9, 2021	149	Notice (Other) (3) Docket Text: NOTICE of Change of Firm Affiliation for William C. Jackson by United Therapeutics Corporation (Flynn, Michael)
Aug 9, 2021	150	Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Marisa Law on August 31, 2021 filed by United Therapeutics Corporation.(Flynn, Michael)
Aug 9, 2021	151	Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Dr. Benjamin Maynor on September 1, 2021 filed by United Therapeutics Corporation.(Flynn, Michael)
Aug 9, 2021	152	Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Jeffrey Kindig on September 2, 2021 filed by United Therapeutics Corporation.(Flynn, Michael)
Aug 9, 2021	153	Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Kelli Collin on September 3, 2021 filed by United Therapeutics Corporation.(Flynn, Michael)
Aug 6, 2021	148	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Rule 30(b)(6) Notice of Deposition of United Therapeutics Corporation filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Aug 4, 2021	143	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Sudersan Tuladhar on August 25, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Aug 4, 2021	144	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Raju Penmasta on August 26, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Aug 4, 2021	145	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Horst Olschewski on August 23, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Aug 4, 2021	146	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Hitesh Batra on September 9, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Aug 4, 2021	147	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of David Walsh on September 10, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Aug 2, 2021	141	Notice (Other) (17) Docket Text: NOTICE of Subpoenas on Dr. Robert Roscigno, by United Therapeutics Corporation. (Flynn, Michael) Modified on 8/2/2021 (nms).
Aug 2, 2021	142	Notice of Service (5) Docket Text: NOTICE OF SERVICE of United Therapeutics Corporation's Objections and Responses to Defendant's Fourth Set of Interrogatories (Nos. 15-16) filed by United Therapeutics Corporation.(Flynn, Michael)
Jul 20, 2021	140	Main Document (15) Docket Text: REDACTED VERSION of [135] Reply Brief by United Therapeutics Corporation. (Attachments: # (1) Exhibit E, # (2) Exhibit M)(Flynn, Michael)
Jul 20, 2021	140	Exhibit E (1)
Jul 20, 2021	140	Exhibit M (12)
Jul 16, 2021	138	Notice (Other) (21) Docket Text: NOTICE of Subpoenas to Globepharm Consulting, Inc., by United Therapeutics Corporation. (Flynn, Michael) Modified on 7/19/2021 (nms).
Jul 16, 2021	139	Notice (Other) (21) Docket Text: NOTICE of Subpoenas to LGM Pharma, LLC, by United Therapeutics Corporation (Flynn, Michael) Modified on 7/19/2021 (nms).
Jul 14, 2021	N/A	Remark (0) Docket Text: Remark: The additional Letter Request and Certified Translation have been signed and sealed by Judge Hall (See D.I. [136]). The documents have been placed in the envelope provided by counsel for FedEx Express mailing. (ceg)
Jul 13, 2021	136	Letter (2) Docket Text: Letter to The Honorable Jennifer L. Hall, from Michael Flynn regarding assistance with Hague request (D.I. [123]). (Flynn, Michael) Modified on 7/13/2021 (nms).
Jul 8, 2021	133	Redacted Document (30) Docket Text: REDACTED VERSION of [128] Answering Brief in Opposition, by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Jul 8, 2021	134	Redacted Document (30) Docket Text: REDACTED VERSION of [129] Exhibit to a Document, by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Jul 7, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Katherine Pappas for United Therapeutics Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Jul 6, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [132] STIPULATION to Extend Time (*Reset Briefing Schedule: re [109] MOTION for Leave to File a Second Amended Complaint. Reply Brief due 7/15/2021). Signed by Judge Richard G. Andrews on 7/6/2021. (nms)
Jul 6, 2021	132	Stipulation to EXTEND Time (1) Docket Text: STIPULATION to Extend Time - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 7/6/2021 (nms).
Jul 2, 2021	131	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Fourth Set of Interrogatories to Plaintiff (Nos. 15-16) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Jul 1, 2021	130	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiff United Therapeutics Corporation's Third Set of Interrogatories to Liquidia Technologies, Inc. (Nos. 11-12) filed by United Therapeutics Corporation.(Flynn, Michael)
Jun 24, 2021	126	Redacted Document (4) Docket Text: REDACTED VERSION of [121] Letter by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Jun 24, 2021	127	Main Document (4) Docket Text: REDACTED VERSION of [120] Letter, by United Therapeutics Corporation. (Attachments: # (1) Exhibit A-C)(Flynn, Michael)
Jun 24, 2021	127	Exhibit A-C (45)
Jun 21, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [122] STIPULATION to Extend Time for the parties to file their joint supplemental claim construction brief to June 21, 2021 (*Reset Deadlines: Joint Supplemental Claim Construction Brief due by 6/21/2021). Signed by Judge Richard G. Andrews on 6/21/2021. (nms)
Jun 21, 2021	N/A	Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Telephone Conference re [81] Motion for Issuance of a Letter of Request for International Judicial Assistance held on 6/21/2021. (*Court Reporter Stacy Vickers.) (ceg)
Jun 21, 2021	123	Order on Motion for Issuance of Letters Rogatory (2) Docket Text: ORDER: IT IS HEREBY ORDERED that the Motion for Issuance of a Letter of Request for International Judicial Assistance is GRANTED (D.I. [81]). Signed by Judge Jennifer L. Hall on 6/21/2021. (ceg)
Jun 21, 2021	N/A	Remark (0) Docket Text: Remark: Certified copies of the Order and Letter of Request will be available on June 22, 2021 for pick-up in the Clerk's Office. (ceg)
Jun 21, 2021	125	Main Document (17) Docket Text: JOINT Submission Regarding Remaining Terms for Claim Construction, filed by United Therapeutics Corporation. (Attachments: # (1) Exhibits J1-J8)(Flynn, Michael) Modified on 6/22/2021 (nms).
Jun 21, 2021	125	Exhibits J1-J8 (464)
Jun 18, 2021	122	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for the parties to file their joint supplemental claim construction brief to June 21, 2021 - filed by United Therapeutics Corporation. (Flynn, Michael)
Jun 16, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [118] MOTION for Pro Hac Vice Appearance of Attorney Brittany Cazakoff, filed by Liquidia Technologies, Inc.. Signed by Judge Richard G. Andrews on 6/16/2021. (nms)
Jun 16, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Brittany Cazakoff for Liquidia Technologies, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Jun 16, 2021	118	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Brittany Cazakoff - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Jun 16, 2021	119	Order (2) Docket Text: SO ORDERED Granting [117] Proposed Claim Construction Order. Signed by Judge Richard G. Andrews on 6/16/2021. (nms)
Jun 15, 2021	N/A	Redaction Notice (0) Docket Text: REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #[110]. (nms)
Jun 15, 2021	116	Main Document (17) Docket Text: REDACTED VERSION of [110] Opening Brief in Support, by United Therapeutics Corporation. (Attachments: # (1) Exhibits A-L)(Flynn, Michael) Modified on 6/16/2021 (nms).
Jun 15, 2021	116	Exs. A-L (108)
Jun 15, 2021	117	Proposed Order (2) Docket Text: PROPOSED Claim Construction Order, by United Therapeutics Corporation. (Flynn, Michael) Modified on 6/15/2021 (nms).
Jun 14, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [115] STIPULATION to Extend Time (*Reset Briefing Schedule: re [109] MOTION for Leave to File a Second Amended Complaint. Answering Brief due 7/2/2021). Signed by Judge Richard G. Andrews on 6/14/2021. (nms)
Jun 11, 2021	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Rescheduling Teleconference: Due to a conflict in the Court's calendar, IT IS HEREBY ORDERED that the teleconference scheduled for June 16, 2021 is RESCHEDULED for June 21, 2021 at 4:00 PM before Judge Jennifer L. Hall. ORDERED by Judge Jennifer L. Hall on 6/11/2021. (ceg)
Jun 11, 2021	115	Stipulation to EXTEND Time (2) Docket Text: STIPULATION to Extend Time - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 6/14/2021 (nms).
Jun 10, 2021	113	Main Document (4) Docket Text: REDACTED VERSION of [106] Letter, by United Therapeutics Corporation. (Attachments: # (1) Exhibits A-C)(Flynn, Michael) Modified on 6/11/2021 (nms).
Jun 10, 2021	113	Exs. A-C (37)
Jun 8, 2021	N/A	Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery Dispute Teleconference held on 6/8/2021. (*Court Reporter Jennifer Guy.) (ceg)
Jun 8, 2021	N/A	Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the discovery dispute teleconference held on June 8, 2021 shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 6/8/2021. (ceg)
Jun 8, 2021	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: A teleconference re [81] Motion for Issuance of a Letter of Request for International Judicial Assistance is scheduled for June 16, 2021 at 1:00 PM Eastern Time before Judge Jennifer L. Hall. By June 14, 2021, each side shall file a letter, not to exceed three pages, addressing any remaining disputes. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. ORDERED by Judge Jennifer L. Hall on 6/8/2021. (ceg)
Jun 7, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Timothy M. Dunker, Jiaxiao Zhang, and William C. Jackson for United Therapeutics Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam)
Jun 4, 2021	N/A	Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 6/4/2021. Counsel for Plaintiff: M. Flynn. Counsel for Defendant: K. Keller. The parties shall submit a proposed order on the first 3 terms covered in the markman hearing. The parties shall file a joint submission for the 2 remaining claim terms on 6/18/2021. (Court Reporter Patrick O'Hare.) (lak)
Jun 4, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER: The Court will entertain oral argument on the pending Motion for Issuance of a Letter of Request for International Judicial Assistance at the discovery dispute hearing currently scheduled for June 8, 2021. Prior to the conference, the parties are ORDERED to meet and confer and discuss in detail each and every request set forth in Exhibits 1 and 2 of the proposed Letter of Request. Delaware counsel must attend the meet and confer. The meet and confer must cover at least the following issues (1) whether the information requested has now been produced; (2) whether any of the requests can and should be narrowed to cover only relevant information and/or reduce the burden on the third party and/or the foreign court; (3) whether three deponents are necessary and whether Plaintiff would be amenable to requesting testimony from a single corporate representative, if permitted by law; (4) whether the requested samples exist; and (5) how the parties' respective positions on the above issues promote the interests of judicial economy, comity, and the just resolution of this matter. The Court further provides the following guidance to aid the parties' discussion. The Court is not inclined to authorize Exhibit 2, Request No. 7. The Court is inclined to substantially narrow Exhibit 2, Request No. 3. If Plaintiff has reason to believe that some, but not all, of the requested manufacturing and analytical testing records (e.g., batch records) have been produced, the Court will likely authorize the corresponding requests notwithstanding that they may call for production of some duplicative information. The Court is not inclined to authorize Exhibit 1, Question 16. The Court is inclined to authorize the remaining 16 questions and is not inclined to rewrite them. To the extent that Plaintiff is requesting Yonsung to "provide samples that do not currently exist" or "make samples" (as Defendant suggests), the Court is not inclined to authorize such a request. ORDERED by Judge Jennifer L. Hall on 6/4/2021. (ceg)
Jun 4, 2021	108	Redacted Document (30) Docket Text: REDACTED VERSION of [105] Letter by Liquidia Technologies, Inc.. (Keller, Karen)
Jun 4, 2021	109	Main Document (6) Docket Text: MOTION for Leave to File a Second Amended Complaint - filed by United Therapeutics Corporation. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Flynn, Michael) Modified on 6/7/2021 (nms).
Jun 4, 2021	109	Ex. 1 - Second Amended Complaint (25)
Jun 4, 2021	109	Ex. 2 - Redline (29)
Jun 1, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [103] MOTION for Pro Hac Vice Appearance of Attorney Joshua Revilla, Jiaxiao Zhang, Katherine Pappas and Timothy Dunker of MCDERMOTT WILL & EMERY LLP, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 6/1/2021. (nms)
Jun 1, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for Exhibits 1-2, P1-P6 found at D.I. [76] has been replaced with a corrected version per counsel's request. Attachments to Exhibit P4 have been added as they were inadvertently omitted at the time of filing. (nms)
May 28, 2021	104	Redacted Document (15) Docket Text: REDACTED VERSION of [99] Reply Brief, by United Therapeutics Corporation. (Flynn, Michael)
May 26, 2021	103	Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Joshua Revilla, Jiaxiao Zhang, Katherine Pappas and Timothy Dunker of MCDERMOTT WILL & EMERY LLP - filed by United Therapeutics Corporation. (Flynn, Michael)
May 25, 2021	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. [98]). A discovery dispute teleconference is scheduled for June 8, 2021 at 2:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than May 28, 2021 the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than June 3, 2021 any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 5/25/2021. (ceg)
May 24, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The main pdf for D.I. [99] has been replaced per counsel's request. The numbering in table of contents has been corrected. (nms)
May 24, 2021	N/A	Order Referring Motion (0) Docket Text: ORAL ORDER: The Motion for Issuance of a Letter of Request for International Judicial Assistance (D.I. [81]) is REFERRED to Magistrate Judge Jennifer L. Hall. Ordered by Judge Richard G. Andrews on 5/24/2021. Motions referred to Jennifer L. Hall.(nms)
May 24, 2021	101	Notice of Service (5) Docket Text: NOTICE OF SERVICE of United Therapeutics Corporation's Objections and Responses to Defendant's Third Set of Interrogatories (No. 14) - filed by United Therapeutics Corporation.(Flynn, Michael)
May 21, 2021	97	Redacted Document (30) Docket Text: REDACTED VERSION of [94] Response to Motion, by Liquidia Technologies, Inc.. (Keller, Karen)
May 21, 2021	98	Motion for Miscellaneous Relief (3) Docket Text: MOTION for Teleconference to Resolve Discovery Dispute - filed by Liquidia Technologies, Inc.. Motions referred to Jennifer L. Hall.(Keller, Karen)
May 19, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Oral Order at D.I. 95 has been corrected to refer to Fed. R. Civ. P. 26. (ceg)
May 19, 2021	96	Redacted Document (4) Docket Text: REDACTED VERSION of [86] Letter by United Therapeutics Corporation. (Flynn, Michael)
May 17, 2021	N/A	Order (0) Docket Text: ORAL ORDER: Having carefully reviewed the parties' letters and attachments (D.I. [84], [86]) regarding the pending Motion for Teleconference to Resolve Discovery Dispute (D.I. [73]) IT IS HEREBY ORDERED that Liquidia's request for an order compelling Dr. Ruffalo (or UTC counsel) to provide sworn responses to twelve questions is DENIED. It is evident that Liquidia's questions seek to determine if and when Dr. Ruffalo consulted with UTC's attorneys regarding briefs filed in IPRs concerning two of the patents-in-suit. (He did not testify in those proceedings.) Disclosure of that information in this proceeding is not required by Fed. R. Civ. P. 26(a)(2); the Court rejects any assertion that the answers to Liquida's questions constitute "facts or data considered by" Dr. Ruffalo in forming his opinions. The record also reflects that UTC has complied with its disclosure obligations under Fed. R. Civ. P. 26(a)(2). Moreover, the Court finds that, under the particular circumstances here, the disclosure of information regarding the fact and timing of Dr. Ruffalo's communications with UTC's attorneys would violate the spirit, if not the letter, of Fed. R. Civ. P. 26(b)(3),(4). The Court is unpersuaded by Liquidia's contention that its questions "seek basic information that would otherwise be included on a privilege log." (D.I. [84] at 3.) If the communications need not be logged, for example, because they were between outside counsel and Dr. Ruffalo, the Court will not require Dr. Ruffalo to answer questions about them. The teleconference scheduled for 5/18 is CANCELLED. SO ORDERED by Judge Jennifer L. Hall on 5/17/2021. (ceg) Modified docket text on 5/17/2021 (ceg). Modified docket text on 5/19/2021 (ceg).
May 14, 2021	92	Redacted Document (30) Docket Text: REDACTED VERSION of [82] MEMORANDUM in Support, by United Therapeutics Corporation. (Flynn, Michael)
May 14, 2021	93	Notice (Other) (4) Docket Text: NOTICE of Change of Firm Affiliation by United Therapeutics Corporation (Flynn, Michael)
May 13, 2021	88	Main Document (5) Docket Text: REDACTED VERSION of [76] Appendix, Volume 1 of 4, by United Therapeutics Corporation. (Attachments: # (1) Exhibits 1-2, P1-P6)(Flynn, Michael) Modified on 5/13/2021 (nms).
May 13, 2021	88	Ex. 1-2, P1-P6 (480)
May 13, 2021	89	Main Document (2) Docket Text: REDACTED VERSION of [77] Appendix, Volume 2 of 4, by United Therapeutics Corporation. (Attachments: # (1) Exhibits D1-D7)(Flynn, Michael) Modified on 5/13/2021 (nms).
May 13, 2021	89	Ex. D1-D7 (341)
May 13, 2021	90	Main Document (2) Docket Text: REDACTED VERSION of [78] Appendix, Volume 3 of 4, by United Therapeutics Corporation. (Attachments: # (1) Exhibits D8-D20)(Flynn, Michael) Modified on 5/13/2021 (nms).
May 13, 2021	90	Ex. D8-D20 (470)
May 13, 2021	91	Main Document (2) Docket Text: REDACTED VERSION of [79] Appendix, Volume 4 of 4, by United Therapeutics Corporation. (Attachments: # (1) Exhibits D21-29, # (2) Exhibits D30-33)(Flynn, Michael) Modified on 5/13/2021 (nms).
May 13, 2021	91	Ex. D21-29 (234)
May 13, 2021	91	Ex. D30-33 (311)
May 12, 2021	87	Redacted Document (30) Docket Text: REDACTED VERSION of [84] Letter by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
May 11, 2021	N/A	Redaction Notice (0) Docket Text: REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of redacted versions of DI #[76], [77], [78], [79], and [82]. (nms)
May 10, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER: Due to a scheduling conflict the Markman hearing scheduled for 5/24/2021, is CANCELED and the hearing is now reset for 6/4/2021, at 9:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 5/10/2021. (nms)
May 4, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER: The Joint Motion for Claim Construction (D.I. [80]) is GRANTED. The hearing will be limited to two hours. Signed by Judge Richard G. Andrews on 5/4/2021. (nms)
May 3, 2021	N/A	Motions No Longer Referred (0) Docket Text: Motions No Longer Referred: [81] MOTION for Issuance of Letters Rogatory for International Judicial Assistance, and [80] Joint Motion for Claim Construction. (nms)
Apr 30, 2021	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. [73]). A discovery dispute teleconference is scheduled for May 18, 2021 at 2:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than May 5, 2021 the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than May 11, 2021 any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 4/30/2021. (ceg)
Apr 30, 2021	75	Joint Claim Construction Brief (30) Docket Text: JOINT Claim Construction Brief, filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 5/3/2021 (nms).
Apr 30, 2021	80	Motion for Miscellaneous Relief (2) Docket Text: Joint Motion for Claim Construction - filed by United Therapeutics Corporation.(Flynn, Michael) Modified on 5/3/2021 (nms). Modified on 5/3/2021 (nms).
Apr 30, 2021	81	Motion for Issuance of Letters Rogatory (7) Docket Text: MOTION for Issuance of a Letter of Request for International Judicial Assistance - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 5/3/2021 (nms).
Apr 29, 2021	72	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Amended Disclosures Under Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Apr 29, 2021	73	Motion for Miscellaneous Relief (2) Docket Text: MOTION for Teleconference to Resolve Discovery Dispute - filed by Liquidia Technologies, Inc.. Motions referred to Jennifer L. Hall.(Hoeschen, Nathan)
Apr 28, 2021	N/A	Order Referring Case to Magistrate Judge (0) Docket Text: ORAL ORDER: The parties contacted chambers to advise of a discovery impasse. Pursuant to the Scheduling Order (D.I. [20]) all discovery disputes including those that may arise in connection with expert reports are now REFERRED to Magistrate Judge Jennifer L. Hall. Ordered by Judge Richard G. Andrews on 4/28/2021. (nms) Modified on 5/3/2021 (nms).
Apr 28, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER: A Motion for Teleconference to Resolve Discovery Dispute should be filed if counsel finds they are unable to resolve a discovery matter. The suggested text for this motion can be found in Judge Hall's portion of the Court's website, in the "Forms" tab, under the heading "Motion for Teleconference to Resolve Discovery/Protective Order Disputes." The dispute will thereafter be addressed in accordance with Judge Hall's discovery dispute procedures. ORDERED by Judge Jennifer L. Hall on 4/28/2021. (ceg)
Apr 28, 2021	71	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Responses and Objections to Plaintiff's Second Set of Requests for Production of Documents (68-77) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Apr 26, 2021	68	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Liquidia Technologies, Inc.'s Third Set of Interrogatories to Plaintiff (No. 14) filed by Liquidia Technologies, Inc..(Keller, Karen)
Apr 19, 2021	67	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Objections and Responses to Defendant's Second Set of Interrogatories (Nos. 8-13) filed by United Therapeutics Corporation.(Flynn, Michael)
Apr 13, 2021	66	Order (2) Docket Text: SO ORDERED Granting [65] Stipulation to Amend Protective Order. Signed by Judge Richard G. Andrews on 4/13/2021. (nms)
Apr 12, 2021	65	Stipulation (2) Docket Text: STIPULATION to Amend Protective Order, by United Therapeutics Corporation. (Flynn, Michael) Modified on 4/13/2021 (nms).
Apr 7, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [64] MOTION for Pro Hac Vice Appearance of Attorney Bill Ward, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 4/7/2021. (nms)
Apr 7, 2021	64	Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bill Ward - filed by United Therapeutics Corporation. (Flynn, Michael)
Apr 5, 2021	63	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Liquidia Technologies, Inc.'s Objections and Responses to Plaintiff's Second Set of Interrogatories (Nos. 2-10) filed by Liquidia Technologies, Inc..(Keller, Karen)
Apr 2, 2021	60	Notice (Other) (3) Docket Text: NOTICE of Change of Firm Affiliation by United Therapeutics Corporation (Blumenfeld, Jack)
Apr 2, 2021	61	Notice Requesting Removal of Co-Counsel (3) Docket Text: NOTICE requesting Clerk to remove Joshua Mack as co-counsel. Reason for request: no longer with firm. (Blumenfeld, Jack)
Apr 2, 2021	62	Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Plaintiff United Therapeutics Corporation's Reply Claim Construction Brief with Respect to U.S. Patent Nos. 9,593,066 and 9,604,901 and (2) Supplemental Declaration of Robert R. Ruffolo, Ph.D. - filed by United Therapeutics Corporation.(Flynn, Michael)
Mar 29, 2021	58	Notice to Take Deposition (2) Docket Text: AMENDED Notice to Take Deposition of Robert R. Ruffolo on April 15, 2021 at 9:00 a.m. EST, filed by Liquidia Technologies, Inc..(Hoeschen, Nathan) Modified on 3/30/2021 (nms).
Mar 29, 2021	59	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff's Second Set of Requests for Production of Documents to Liquidia Technologies, Inc. (68-77) - filed by United Therapeutics Corporation.(Flynn, Michael)
Mar 18, 2021	57	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.s Second Set of Interrogatories to Plaintiff (Nos. 8-13) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Mar 4, 2021	56	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff United Therapeutics Corporation's Second Set of Interrogatories to Liquidia Technologies, Inc. (Nos. 2-10) - filed by United Therapeutics Corporation.(Flynn, Michael)
Feb 8, 2021	55	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Robert R. Ruffolo on February 17, 2021 filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Feb 5, 2021	54	Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Plaintiff United Therapeutics Corporation's Opening Claim Construction Brief with Respect to U.S. Patent Nos. 9,593,066 and 9,604,901, (2) Declaration of Joshua Mack in Support of Plaintiff United Therapeutics Corporation's Opening Claim Construction Brief with Respect to U.S. Patent Nos. 9,593,066 and 9,604,901 and (3) Declaration of Robert R. Ruffolo, Ph.D. - filed by United Therapeutics Corporation.(Flynn, Michael)
Jan 8, 2021	52	Main Document (2) Docket Text: Joint Claim Construction Chart, Volume 1 of 2, by United Therapeutics Corporation. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, part 1, # (4) Exhibit C, part 2)(Flynn, Michael) Modified on 1/8/2021 (nms).
Jan 8, 2021	52	Exhibit A (16)
Jan 8, 2021	52	Exhibit B (126)
Jan 8, 2021	52	Exhibit C, part 1 (124)
Jan 8, 2021	52	Exhibit C, part 2 (329)
Jan 8, 2021	53	Main Document (2) Docket Text: Joint Claim Construction Chart, Volume 2 of 2, by United Therapeutics Corporation. (Attachments: # (1) Exhibit C, part 3, # (2) Exhibit C, part 4)(Flynn, Michael) Modified on 1/8/2021 (nms).
Jan 8, 2021	53	Exhibit C, part 3 (547)
Jan 8, 2021	53	Exhibit C, part 4 (21)
Dec 17, 2020	51	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Objections and Responses to Defendant's First Set of Interrogatories (Nos. 1-7) filed by United Therapeutics Corporation.(Blumenfeld, Jack)
Nov 23, 2020	50	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Liquidia Technologies, Inc.'s Objections and Responses to Plaintiff's First Set of Interrogatories (No. 1) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Nov 17, 2020	48	Answer to Counterclaim (16) Docket Text: ANSWER to [23] Answer to Amended Complaint, and Counterclaim, by United Therapeutics Corporation.(Flynn, Michael) Modified on 11/17/2020 (nms).
Nov 17, 2020	49	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s First Set of Interrogatories to Plaintiff (Nos. 1-7) filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Nov 13, 2020	47	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Preliminary Invalidity Contentions filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Nov 6, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Art P. Dykhuis for United Therapeutics Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
Nov 4, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [46] MOTION for Pro Hac Vice Appearance of Attorney Douglas W. Cheek, filed by Liquidia Technologies, Inc.. Signed by Judge Richard G. Andrews on 11/4/2020. (nms)
Nov 3, 2020	45	Memorandum and Order (3) Docket Text: MEMORANDUM ORDER: The Motion to Dismiss Invalidity Counterclaims and Defenses (D.I. [28]) is DENIED. Signed by Judge Richard G. Andrews on 11/3/2020. (nms)
Nov 3, 2020	46	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Douglas W. Cheek - filed by Liquidia Technologies, Inc.. (Hoeschen, Nathan)
Nov 2, 2020	44	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Liquidia Technologies, Inc.'s Responses and Objections to Plaintiff's First Set of Requests for the Production of Documents (1-67) filed by Liquidia Technologies, Inc..(Keller, Karen)
Oct 30, 2020	43	Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: A Telephone Conference is set for 12/11/2020 at 12:30 PM Eastern Time with Judge Mary Pat Thynge to discuss ADR. Plaintiffs' counsel to initiate the call. Signed by Judge Mary Pat Thynge on 10/30/20. (cak)
Oct 26, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [42] MOTION for Pro Hac Vice Appearance of Attorney Art Dykhuis, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 10/26/2020. (nms)
Oct 26, 2020	42	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Art Dykhuis - filed by United Therapeutics Corporation. (Flynn, Michael)
Oct 22, 2020	41	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff United Therapeutics Corporation's First Set of Interrogatories to Liquidia Technologies, Inc. (No. 1) filed by United Therapeutics Corporation.(Flynn, Michael)
Oct 16, 2020	40	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff United Therapeutics Corporation's Preliminary Infringement Contentions - filed by United Therapeutics Corporation.(Flynn, Michael)
Oct 1, 2020	39	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff's First Set of Requests for Production of Documents to Liquidia Technologies, Inc. (1-67) filed by United Therapeutics Corporation.(Flynn, Michael)
Sep 16, 2020	38	Reply Brief (17) Docket Text: REPLY BRIEF re [28] MOTION to Dismiss Invalidity Counterclaims and Defenses filed by United Therapeutics Corporation. (Flynn, Michael)
Sep 9, 2020	37	Answering Brief in Opposition (27) Docket Text: ANSWERING BRIEF in Opposition re [28] MOTION to Dismiss Invalidity Counterclaims and Defenses filed by Liquidia Technologies, Inc..Reply Brief due date per Local Rules is 9/16/2020. (Hoeschen, Nathan)
Sep 3, 2020	36	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Responses and Objections to Liquidia's First Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 1-80) filed by United Therapeutics Corporation.(Blumenfeld, Jack)
Aug 31, 2020	33	Order (19) Docket Text: SO ORDERED Granting [32] Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 8/28/2020. (nms)
Aug 31, 2020	34	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Liquidia Technologies, Inc..(Hoeschen, Nathan)
Aug 31, 2020	35	Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) United Therapeutics Corporation's Initial Disclosures Pursuant to Paragraph 4 of the District of Delaware Default Standard for Discovery and (2) United Therapeutics Corporation's Initial Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by United Therapeutics Corporation.(Flynn, Michael)
Aug 28, 2020	32	Proposed Order (19) Docket Text: PROPOSED Stipulated Protective Order, by Liquidia Technologies, Inc.. (Hoeschen, Nathan) Modified on 8/28/2020 (nms).
Aug 26, 2020	28	Motion to Dismiss for Failure to State a Claim (4) Docket Text: MOTION to Dismiss Invalidity Counterclaims and Defenses - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 8/26/2020 (nms).
Aug 26, 2020	29	Opening Brief in Support (21) Docket Text: OPENING BRIEF in Support re [28] MOTION to Dismiss Invalidity Counterclaims and Defenses, filed by United Therapeutics Corporation.Answering Brief/Response due date per Local Rules is 9/9/2020. (Flynn, Michael) Modified on 8/26/2020 (nms).
Aug 26, 2020	30	Statement (11) Docket Text: Request for Judicial Notice in Support of Motion to Dismiss Defendant's Counterclaim, by United Therapeutics Corporation. (Flynn, Michael) Modified on 8/26/2020 (nms).
Aug 26, 2020	31	Main Document (5) Docket Text: DECLARATION of Joshua Mack re [28] MOTION to Dismiss Invalidity Counterclaims and Defenses, by United Therapeutics Corporation. (Attachments: # (1) Exhibits 1-9)(Flynn, Michael) Modified on 8/26/2020 (nms).
Aug 26, 2020	31	Exs. 1-9 (983)
Aug 25, 2020	27	Order (2) Docket Text: ORDER ON PROTECTIVE ORDER DISPUTE (see Order for further details). Signed by Judge Richard G. Andrews on 8/25/2020. (nms)
Aug 21, 2020	26	Main Document (6) Docket Text: Joint Letter to The Honorable Richard G. Andrews from Nathan R. Hoeschen and Jack B. Blumenfeld regarding Protective Order. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Hoeschen, Nathan)
Aug 21, 2020	26	Exhibit A (20)
Aug 21, 2020	26	Exhibit B (7)
Aug 14, 2020	25	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by United Therapeutics Corporation.(Blumenfeld, Jack)
Aug 10, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [24] STIPULATION TO EXTEND TIME to submit a Protective Order to August 14, 2020. Signed by Judge Richard G. Andrews on 8/10/2020. (nms)
Aug 10, 2020	24	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit a Protective Order to August 14, 2020 - filed by Liquidia Technologies, Inc.. (Keller, Karen)
Aug 5, 2020	N/A	Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak)
Aug 5, 2020	22	Transcript (6) Docket Text: Official Transcript of Scheduling Conference held on 7/30/20 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/26/2020. Redacted Transcript Deadline set for 9/8/2020. Release of Transcript Restriction set for 11/3/2020. (Triozzi, Heather)
Aug 5, 2020	23	Answer to Amended Complaint (26) Docket Text: ANSWER to [16] Amended Complaint, COUNTERCLAIMS and Affirmative Defenses against United Therapeutics Corporation, by Liquidia Technologies, Inc..(Castellano, Jeffrey) Modified on 8/5/2020 (nms).
Aug 4, 2020	21	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants First Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 1-80) filed by Liquidia Technologies, Inc..(Castellano, Jeffrey)
Jul 31, 2020	19	Main Document (12) Docket Text: PROPOSED Scheduling Order, by United Therapeutics Corporation. (Attachments: # (1) Letter)(Blumenfeld, Jack) Modified on 7/31/2020 (nms).
Jul 31, 2020	19	Letter to the Honorable Richard G. Andrews (1)
Jul 31, 2020	20	Scheduling Order (12) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for discovery. Joinder of Parties due by 6/4/2021. Amended Pleadings due by 6/4/2021. Fact Discovery completed by 9/17/2021. Dispositive Motions due by 11/2/2021. Joint Claim Construction Brief due by 4/30/2021. A Markman Hearing is set for 5/24/2021, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 3/4/2022, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set for 3/28/2022, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 7/31/2020. (nms)
Jul 30, 2020	N/A	Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Rule 16(b) Telephone Conference held on 7/30/2020. Counsel for Plaintiff: J. Blumenfeld. Counsel for Defendant: K. Keller. (Court Reporter Heather Triozzi.) (lak)
Jul 28, 2020	18	Main Document (13) Docket Text: PROPOSED Scheduling Order, by United Therapeutics Corporation. (Attachments: # (1) Letter)(Flynn, Michael) Modified on 7/28/2020 (nms).
Jul 28, 2020	18	Letter to The Honorable Richard G. Andrews (1)
Jul 22, 2020	16	Main Document (21) Docket Text: First AMENDED COMPLAINT against Liquidia Technologies, Inc. - filed by United Therapeutics Corporation. (Attachments: # (1) Exhibits A-C)(Blumenfeld, Jack) Modified on 7/27/2020 (nms).
Jul 22, 2020	16	Exhibits A-C (53)
Jul 22, 2020	17	Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,716,793 . (Blumenfeld, Jack)
Jul 22, 2020	16	Amended Complaint* (1)
Jul 21, 2020	14	Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 7/30/2020, at 2:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 7/21/2020. (nms)
Jul 21, 2020	15	Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews, from Jack Blumenfeld, regarding dial-in information for the July 30, 2020 scheduling teleconference. (Blumenfeld, Jack) Modified on 7/21/2020 (nms).
Jul 17, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [13] MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan Davies, Erik B. Milch, Ivor Elrifi, Lauren Krickl and Deepa Kannappan, filed by Liquidia Technologies, Inc.. Signed by Judge Richard G. Andrews on 7/17/2020. (nms)
Jul 17, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Sanya Sukduang, Jonathan R. Davies, Erik B. Milch, Ivor Elrifi, Lauren Krickl, Deepa Kannappan for Liquidia Technologies, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
Jul 16, 2020	11	Answer to Complaint (21) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIM against United Therapeutics Corporation by Liquidia Technologies, Inc..(Keller, Karen) Modified on 7/17/2020 (nms).
Jul 16, 2020	12	Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Liquidia Technologies, Inc.. (Keller, Karen)
Jul 16, 2020	13	Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan Davies, Erik B. Milch, Ivor Elrifi, Lauren Krickl and Deepa Kannappan - filed by Liquidia Technologies, Inc.. (Keller, Karen)
Jun 26, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION and Order to Extend Time (*Reset Answer Deadlines: Liquidia Technologies, Inc. answer due 7/27/2020). Signed by Judge Richard G. Andrews on 6/26/2020. (nms)
Jun 25, 2020	10	Stipulation to EXTEND Time (1) Docket Text: STIPULATION and Order to Extend Time - filed by Liquidia Technologies, Inc.. (Fry, David) Modified on 6/26/2020 (nms).
Jun 12, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Douglas H. Carsten for United Therapeutics Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
Jun 12, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Joshua Mack for United Therapeutics Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
Jun 11, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney Douglas H. Carsten, Joshua Mack and Adam W. Burrowbridge, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 6/11/2020. (nms)
Jun 11, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [9] MOTION for Pro Hac Vice Appearance of Attorney William C. Jackson, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 6/11/2020. (nms)
Jun 11, 2020	8	Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Douglas H. Carsten, Joshua Mack and Adam W. Burrowbridge - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 6/11/2020 (nms).
Jun 11, 2020	9	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William C. Jackson - filed by United Therapeutics Corporation. (Flynn, Michael)
Jun 10, 2020	N/A	Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
Jun 5, 2020	7	Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by United Therapeutics Corporation. Liquidia Technologies, Inc. served on 6/5/2020, answer due 6/26/2020. (Blumenfeld, Jack)
Jun 4, 2020	1	Main Document (15) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Liquidia Technologies, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2974028.) - filed by United Therapeutics Corporation. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(nmg)
Jun 4, 2020	1	Exhibit A-B (27)
Jun 4, 2020	1	Civil Cover Sheet (1)
Jun 4, 2020	2	Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg)
Jun 4, 2020	3	ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/27/2020. Date of Expiration of Patent: 12/15/2028.Thirty Month Stay Deadline: 10/27/2022. (nmg)
Jun 4, 2020	4	Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,593,066 B2; 9,604,901 B2. (nmg)
Jun 4, 2020	5	Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock Inc. for United Therapeutics Corporation filed by United Therapeutics Corporation. (nmg)
Jun 4, 2020	6	Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (nmg)
Jun 4, 2020	1	Complaint* (1)

Lawsuits

United Therapeutics Corporation v. Liquidia Technologies, Inc. > Documents